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 INTRODUCTION 
 The siddha system of medicine is considered as one of the traditional 
medicine formulated by siddhars. It’s a medical science through which the body as 
well as the soul is treated. 
 “Neha;ehb Neha; Kjy; ehb mJ jzpf;Fk; 
  tha; ehb tha;g;gr; nray;” 
 The siddha system is based on the Tridosha theory and Pancha bootha 
theory in assessing and treating the diseases. Prevention and cure are the basic 
aims of all system of medinice whereas the siddha system has in addition the 
transcendental motivation of immortality of the body. 
 There are many branches in the siddha system. Among this Balavagadam is 
considered for the children. It deals with the childhood diseases and their 
treatment. Mainly herbs are issued for treating the childhood diseases. 
 The main of siddha system is to prevent the diseases by proper diet and 
relexation of mind. 
In Balavagadam the diseases are classified into 2 types. 
    i) Agakarana Noigal 
    ii) Purakarana Noigal 
 The disease kudal kirumi -Masarai puzhu is considered as a preventable 
disease It sometimes remains asymptomatic and is not noticed by the parents, 
which may lead to complications. Many children are affected by kudal kirumi 
disease mainly due to poor hygiene. 
 As a step towards the healthy children against worms author had selected 
the topic kudal kirumi- Masarai puzhu. It’s compared with the modern medicine 
and its prognosis with the trail medicine “Nayuruvi Nei” 
 There are several preparations for- treating the kudal kirumi - Masarai 
Puzhu disease. Due to the pure herbal form the author had chosen the medicine 
“Nayuruvi Nei” as the trail drug. for treating the kudal kirumi  - Masarai 
Puzhu” 
 
 
 AIM AND OBJECTIVES 
1. The principle aim of the study of Kudal kirumi- Masarai Puzhu with 
clinical study is to collect and review the ideas of the ancient siddhars about 
this disease.  To reduce the recurrence of symptoms, to create awareness 
among the patients and their parents about the disease and its complications 
and educate them to improve their personal hygiene, sanitation and dietary 
habits. 
2. Collection and detailed study of various literatures dealing with the 
aetiology, classification, signs and symptoms, prognosis, complications, 
diet and treatment of Masarai Puzhu ( Giardiasis) 
3. To have an idea about the incidence of the disease with reference to the age, 
sex, occupational, orientation, socio economic status etc. 
4. To make a comparative study on Siddha system and Modern aspect of this 
disease. 
5. To have clinical trail with specific medicine of Nayurvi Nei. It is given to 
both Outpatient and Inpatient ward in Government Siddha Medical College, 
Palayamkottai. 
6. To study the Biochemical, Pharmarological actions and Antimicrobial 
actions of the trail drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
SIDDHA ASPECTS 
Fly; fpUkp - kriu GO 
ngah; fhuzk; 
      fpUkp> clk;gpw;Fs; fhzg;gLk; mNdf tpjkhd GO 
my;yJ G+r;rpfs;. 
Worms or Parasites of various shapes which germinate or 
grow in a living organism in the different parts of the human 
body.  The different kinds that have their origin in feces, 
phlegm, blood etc.. 
Flw;fpUkp : kdpjTlk;gpy; FlYs; rhjhuzkha; trpf;Fk; fpUkpfs; 
 
Flw;G+r;rp   -  Intestinal worm 
GO    - fpUkp> Worm 
fpUkp    - GO vermicle 
Mjhuk;- T.V rhk;grptk;gps;is mfuhjp (II,V) 
gf;f vz; : 510> 530> 1451 
kaphpioapd; Edp Nghd;w xU tpj GOtpd; Nflhy; tUk; Neha; Mjyhy; 
,jw;F krwp vdg; ngah; te;jJ. 
  “kaphpioapd;  Edp Nghd;W GOf;fSw;W 
   kfTe;jp gpir jyjha; Fotp Nrhh;e;J 
   gaph; thLk; epyik nadj;jiy naohJ 
   gUQ;rPj ePh;kyq;fspil fope;J 
   caph; %yk; Neha; Nghd;W tphpe;J js;sp 
   cld; typj;Jf; Fj;jp J}Jsq;fha; ePh; Nghy; 
   Jah; nghrpe;J fha;r;rnyhL tPf;fk; ff;fy; 
   njhle;Jthpd; krwp Neha; Fwpahnkd;Nd 
Mjhuk; : kjiy Neha; njFjp - I 
         gf;f vz; - 376 
 
 ,ay; 
 Flypy; kpFe;j mstpy; fpUkpfs; cz;lhtjhy; tapw;Wtyp> ,rpT> 
kyf;fl;L my;yJ fopr;ry;> rUkj;jpy; mhpg;G> the;jp> Ruk; cly; fhq;if 
Nghd;witfis cz;lhf;Fk; Neha; 
           Mjhuk; : gps;is gpzp kUj;Jtk; 
         gf;fk;  vz; : 89 
fpUkp Nuhfj;jpd; tiffis gy;NtW E}w;fspy; fPo; fhZkhW 
Fwpf;fg;gl;Ls;sJ. mitfSs; rpytiffs; fpNo Fwpg;gplg;gl;Ls;sd 
 
Flw;fpUkpapd; tiffs; 
1. ehfg;G+r;rp 
2. ngUk;G+ehfk; 
3. ePh;g;ghk;Gf; fpUkp 
4. ney; Kisf; fpUkp 
5. rd;dpePh;f;fpUkp 
6. mZf;fpUkp 
7. ntz;fpUkp 
8. nrq;fpUkp 
9. me;jh; kyf;fpUkp 
10. tl;lf; fpUkp 
11. #l;rk fpUkp 
12. Njhd;whf fpUkp 
13. ePh;f;fpUkp 
14. kQ;rs; fpUkp 
15. fUq;fpUkp 
16. tha;f;fpUkp 
17. tapw;W fpUkp 
18. Fly; fpUkp 
19. <uy; fpUkp 
20. fPhpg;G+r;rp 
21. jpkph; G+r;rp 
22. fizf; fpUkp 
 23. gl;ilg;G+r;rp 
24. E}y; G+r;rp 
25. rhl;ilg;GO 
26. jhdg;GO 
27. kriug;GO 
Mjhuk; : gps;is gpzp kUj;Jtk; 
        gf;f vz; :88>89 
Fly; fpUkpfspd; tiffis gw;wp ntt;NtW E}y;fspy; fhz;Nghk;. 
I . ghythflk; 
1. kriu GO 
2. fPhpg; G+r;rp 
3. ehf;Fg; G+r;rp 
II   gps;isg;gpzp kUj;Jt E}ypy; 27 tif Flw;fpUkpfis gw;wp tpsf;fp 
cs;sJ. mitfs; 
1. 19 tif fpUkpfs; 
2. 5 tif G+r;rpfs; 
3. 3 tif GOf;fs; 
1.G+r;rpfspd; tiffs; 
 1. ehfg; G+r;rp 
 2. fPhpg; G+r;rp 
 3. jpkph;g; G+r;rp 
 4. gl;ilg; G+r;rp 
  5. E}y; G+r;rp 
2.fpUkpfspd; tiffs; 
 1. ePh; ghk;G fpUkp 
 2. ney; Kisf; fpUkp 
 3. rd;d ePsf; fpUkp 
 4. mZf; fpUkp 
 5. ntz;fpUkp 
 6. nrq;fpUkp 
 7. me;jh; kyf; fpUkp 
  8. tl;lf; fpUkp 
 9. #l;rkf; fpUkp 
 10. Njhd;whf; fpUkp 
 11. ePh;f;fpUkp 
 12. kQ;rs; fpUkp 
 13. fUq;fpUkp 
 14. tha;f;fpUkp 
 15. tapw;Wf;fpUkp 
 16. Fly; fpUkp 
 17. <uy; fpUkp 
 18. fizf;fpUkp 
 19. ngUk; G+ ehfk; 
3. GOf;fspd; tiffs; 
 1. rhl;ilg;GO 
 2. jhdg;GO 
 3. kriug;GO 
III kjiy Neha; njhFjp E}ypd;gb 4 tif fpUkpfis gw;wp tpsf;fp                 
 cs;sJ> mitfs ; 
1. thjf;fpUkp 
2. nuj;j fpUkp 
3. gpj;j fpUkp 
4. fg fpUkp 
1.thjf;fpUkpapd; Fzk;: 
   “kyj;jpdpy; fpUkpahNy kdkjhy; fpufzpAz;lhk; 
    gpyj;Jld; mhpaW jhDk; gpuz;lNjhh; %yNeha;fs; 
   ryj;Jld; Fly; thAf;fs; rfpahj NtjidAz;lhk; 
  cyh;j;jpLk; thjk; kPwp cWg;ngy;yhk; cisr;ry;jhNd”  
 
nghUs;: 
 thjfpUkpahy; fpufzp> %yNeha;> Fly;thA> cisr;ry; 
Kjypa FwpFzq;fs; cz;lhFk;. 
  
  2.nuj;j fpUkpapd; Fzk;  
   “fhZNk nuj;j fpUkp fz;bby; thjk; Nkfk; 
    G+ZNk Nkf ntl;il Gife;jpLk; jZg;GCuy; 
     ehZNk nrhwp rpuq;F ehl;lkha; fpue;j #iy 
     tPZNk gUf;fs; F\;lk; trw;G Neha;fug;gd; fhNz”  
nghUs;: 
   nuj;j fpUkpahy; thjk;> Nkfk;> Nkftl;il>nrhwp> rpuq;F>     
 fpue;jp> #iy> Fl;lk;> fug;ghd; ,itfs; cz;lhFk;. 
 
  3.gpj;j fpUkpapd; Fzk; 
 “gpj;jj;jpy; fpUkp jd;id Ngrpby; md;dk; Ntz;lhk; 
  xj;jNjhh; tapw;wpy; NehT clnyq;Fk; tpsh;r;ir fhl;Lk; 
  nkj;jNt jsh;r;ir rh;j;jp Nktpa mjprhuk; jhd; 
  fj;jNt fha;r;rYz;lhk; fz; jiy fpwf;fkhNk”  
nghUs;: 
  gpj;j fpUkpapdhy; grpapd;ik> tapw;wpy; NehT> mjprhuk;> 
 fha;r;ry; Kjypad cz;lhFk;. 
  
4.fg fpUkpapd; Fzk; 
   “fz;bLk; fgf; fpUkp fbdkha; fhaj;jhNy 
    nfhz;bLk; clypy; nuj;jk; nfhjpj;J J}hpj;J gw;wp 
    kz;bLk; fha;r;ry; <is kyk; rpf;fp fgj;ijf; fhl;Lk; 
    tpz;bLk; raNeha; Nrh;e;J tpswpLk; clk;G jhNd”  
nghUs;: 
  fgf;fpUkpahy; clypy; ,uj;jk; nfhjpj;J fha;r;ry;> <is> 
 kyf;fl;L> raNeha; Kjypad cz;lhFk;. 
 
 
 
 
 
 IV [Ptul;rhkph;jk; E}ypd; fPo; 20 tif fpUkpfis 4 gphpTfshf 
 tpsf;f gl;Ls;sJ. mitfs; 
1. rhPuj;jpd; Nky; ,Ug;gd 
2. fgj;jpy; ,Ug;gd 
3. ,uj;jj;jpy; ,Ug;gd 
4. kyj;jpy; ,Ug;gd 
 
1.rhPuj;jpd; Nky; ,Ug;gd 
Ngd;, rPiyg;Ngd; vd 2 tifg;gLk;. Ngd; mOf;fpy; gpwe;J 
cNuhkq;fspd; eLNt trpf;Fk;. rPiyg;Ngd;fs; mOf;fpy; gpwe;J 
mOf;Fj;Jzpfspy; trpf;Fk;. ,it fbg;gjpdhy; jpdT , jbg;G rpwpa 
nfhg;Gsq;fs; Kjypad cz;lhFk;. 
 
2.fgj;jpy; ,Ug;gd 
fgj;jpy; Mkha];jhdj;jpy; gpwe;J tpUj;jpahfp cs;rQ;rhpg;gJ 
ngUk; G+ehff; fpUkp , ney;Kisf; fpUkp, rd;d ePsf; fpUkp, mZf;fpUkp, 
ntz;fpUkp, nrq;fpUkp vd VO tifg;gLk;. ,itj; jdpj;jdpahfTk;, 
$l;lq;$l;lkhfTk;> fhypy;yhkYk;, tl;lkhf Rw;wpa E}iyg;NghYk; 
ghh;itf;F Gyg;glhj mZg;NghYk; jUg;igg; G+ thridiag; ngw;W 
Flypy; rQ;rhpf;fpd;wd. 
 
3.,uj;jj;jpy; ,Ug;gd 
 cjpuj;jpy; gpwe;J tpUj;jpahfp ,uj;j ehsq;fspy; rQ;rhpg;gJ 
mZf;fpUkp ,tl;lf;fpUkp, kpUf#\;kf;fpUkp, fhypy;yhf;fpUkp, nrq;fpUkp, 
Njhw;whf;fpUkp vd MW tifg;gLk;. 
 
4.kyj;jpy; ,Ug;gd 
 gf;Fthra];jhdj;jpy; gpwe;J tsh;e;J kyhraj;jpy; rQ;rhpg;git 
fNfUfk;, kNfUfk;, rTurk;, rY}dk; , Nyfk; vd 5 tifg;gLk;. NkYk; 
,tw;Wld; gl;ilg;G+r;rp> tl;lg;G+r;rp Nghd;w G+r;rpfSk; Flypy; 
trpf;fpd;wd vd [Ptul;rhkph;j E}y; $WfpwJ.  
 V) T.V rhk;grpt gps;is E}ypd; fPo; Fly;fpUkpapd; tiffs; 
m. G+r;rp : 
 gy;NtW tifahd G+r;rpfs; 
1. ehfg;G+r;rp - Round Worm ( Ascariasis) 
2. fPhpg;G+r;rp  - Small Parasites or microbes 
3. jpkph;g;G+r;rp - Small Parasites in the Intestine (Oxyuriasis) 
4. E}y;g;G+r;rp - Thread Worm (Enterobius Vermicularis) 
M. fpUkp : 
 gy;NtW tifahd fpUkpfs; 
1. ePh;g;ghk;G   - An Unknown Kind 
2. ney; Kisf;fpUkp   - HookWorm (Ankylostoma Duodenale) 
3. rd;d ePsf; fpUkp  - Filaria 
4. mZf; fpUkp   - Microbe 
5. ntz;fpUkp   - White Worm 
6. nrq;fpUkp   - Red Worm 
me;jh; kyf; fpUkp  - Worms of the rectum (Oxyuris                
                         Vermicularis) 
7. tl;lf; fpUkp   -  Round Worm(Ascariasis) 
8. #l;rkf; fpUkp  - Microzoan 
9. Njhd;whf; fpUkp  - Invisible Worm 
10. ePh;f;fpUkp   - Water Worm 
11. kQ;rs; fpUkp   - Yellow Coloured Worm 
12. fUq;fpUkp   - Black Coloured Worm 
13. tha;f;fpUkp   - Worms found in the teeth, saliva etc 
14. tapw;Wf;fpUkp   - Germs in the stomach 
15. Fly; fpUkp   - Intestinal worms such as tape worm  
      Round worm 
16. <uy; fpUkp   - Liver Flukes (facioli Hepativa) 
17. fizf;fpUkp   - Germs responsible for kanam 
18. ngUk; G+ ehfk;  - Round Worm 
 ,) GO  
   gy;NtW tifahd GOf;fs; 
 
1. kriug;GO (nrwp GO)  - A kind of worm in the intestine   
                                                             Giardiasis 
2. jl;ilg;GO (or) ehlhg;GO - Tape Worm 
Taenia saginata   - beef tape worm(khl;biwr;rp ehlhg;GO) 
Taenia Soliumm    - Pork tape worm (gd;wp ,iwr;rp ehlhg;GO) 
<) Worms of Intestine 
   List of worm present in intestine  
       
    1.ePh; ghk;G fpUkp   - An unknown kind 
      2.ney; Kisf; fpUkp   - Hook worm (Ankylostoma duodenale) 
3.rd;d ePsf; fpUkp   - Filaria 
4.mZf; fpUkp     - Microbe 
5.ntz;fpUkp    - White worm 
6.tl;lf; fpUkp     - Round Worm(Ascaris) 
7.ngUk;G+ehff; fpUkp   - Round Worm 
8.#l;rkf; fpUkp   - Microzoan 
9.Njhd;whf; fpUkp   - Invisible worm 
c. Germs of blood 
   The different types of germs in the blood are 
1. mZf; fpUkp  - Microbe 
2. tl;lf; fpUkp  - Round worm (Ascariasis) 
3. kpf #l;rkf; fpUkp - Microzoan 
4. fhypy;yhf; fpUkp  - Worms without legs for locomotion 
5. Njhd;whf; fpUkp  - Invisible worm 
6. nrq;fpUkp   - Red worm 
 
 
 fpUkpf;F nghJf;Fzk; (kjiy Neha; njhFjp - 1 y; gf;f vz; 296y;  
 Fzkhd ,sk; Ngjp jd;id thl;b 
  nfhw;wtNd %ykjpy; mdy; jhd; nfhz;L 
kzpjpuz;L cs;Nkfj; Jwf;fkhFk; 
  jpzkhd nuj;jkJ J}\pj;J tw;wp 
jtwhky; NgjpajpNy gOj;J 
  jpzkhd NgjpaJ ,wq;Fk; NghJ  
Nuhfp nkj;j fpUkpaJ mjdpy; $l;b 
  fdkhd MfhukJ Fiwe;J the;jp  
fbdKld; gplhp ,Lg;Gise;J fha;e;J 
 kdkhd Njfkjpy; twl;ir ke;jk;  
ike;jNd NkhfkJ Fiwj;J fhl;Lk; 
 khdplj;jpy; khe;jUf;F fpUkp NehNa. 
 
FwpFzq;fs;:  
  NgjpAld; fpUkp fhzy;> ,Lg;G cisjy;>Njfj;jpy; twl;rp 
Vw;gly;> ke;j Neha; Nghd;w FwpFzq;fs; cz;lhFk;. 
 
fpUkpf;F nghJFzk; ( Nehapy;yh newp) 
Nehapy;yh newpapy; $wg;gl;l gb fpUkpfshy; fPo; fhZk; Fw;wq;fs; 
cz;lhfpwJ vd;W $wg;gl;Ls;sJ. 
fpUkpahy; te;jNjhlk; ngUf Tz;L 
 Nfl;fyjd; gphpTjidf; fpukkhf 
nrUkptUk; gTj;uq;fs; fpUkpahNy 
  nghUkptUk; tha;ntyhk; fpUkpahNy 
 jpNufkjpy; nrhhpf;Fl;lk; fpUkpahNy 
 JUkptUk; RNuhzpjq; fpUkpahNy 
 #l;rKld; fphpifg;ghy; njhopy; nra;tPNu 
         -FU ehb. nra; 93 
 
 
 Nkw;$wpa nra;Ashy; gy Neha;fSf;Fk; fpUkpfNs fhuz 
nkd;wwpayhk;. 
fpUkpapdhy; tha;T> GOf;fb> gTj;jpuk;> nrhhp> Fl;lk; Nghd;w 
Neha;fs; cz;lhFk;. 
NkYk; Fly;fspy; jq;Fk; fpUkp midj;Jk; jPikfs; kl;LNk 
mspg;gJ my;yhky; ed;ikfs; nra;Ak; fpUkpfSk; cs;sjhf Nehapy;yh 
newp E}ypy; $wg;gl;Ls;sJ.  
 cztpd; gphpT $Wkplj;jpy;> fhw;gq;F czT fpUkpfSf;F 
vd;W nrhy;yg;gl;Ls;sJ. jPik nra;Ak; fpUkpfSf;F cztspj;J tsh;f;f 
Ntz;Lnkd;W vtUk; $whh;. Mifahy; mq;Ff; $wg;gLk; fpUkpfs; 
A+fpf;fg;gLfpwJ. msTf;F kpQ;rpdhy; mkph;jKk; tp\khFk;> Mjypd; 
mf;fpUkpfs; mjpfg;gbDk; my;yJ ,lk; tpl;L ,lk; nry;ypDk; 
tp\khff;$Lk;. vdNt xNu fpUkp ed;ikAk; gaf;ff;$Lk;. fpUkpahy; 
kl;Lkpd;wp mjd; tp\ ePuhYk; rh;k Neha;fs; cz;lhf $Lk.; 
krwp tif 
 
1. Ez; krwp 
2. ntz; krwp 
3. kQ;rs; krwp 
4. fUkrhp 
5. nfhOfy; krwp 
      Mjhuk; : kjiy Neha; njhFjp -I 
         gf;fk; vz; -377 
Neha;f;fhd fhuzq;fs; (nghJ) 
 J}a;ikaw;w kyk; fye;j kz;zpy; tpisahLtjhYk; 
 kz;iz jpd;gjhYk;> < nkha;j;j gz;lq;fs>; J}a;ikaw;w czT> 
fha;fwpfs;> goq;fs; Mfpatw;iw cz;gjhYk;> 
 nfl;L Nghd japh;> gioa rhjk; mOfpa fha;fwpfs;> goq;fs; 
,tw;iw cz;gjhYk; gd;wp ,iwr;rp> khl;L ,iwr;rpahYk;> rpy 
kPd; tiffis cz;gjhYk;>  
  eha;> G+id Nghd;w tPl;L tsh;g;G gpuhzpfsplk; neUf;fkhf 
goFtjhYk; Fly; fpUkpfs; cz;lhfpd;wd. 
 NkYk; rpy G+r;rpfs; Mrd thapy; Kl;ilapLfpd;wd 
Foe;ijahdJ Mrd gFjpapy; mhpf;Fk; NghJ ifapid itj;J 
Ruz;LfpwJ. gpwF mNj tpuypid thapy; itj;J #g;Gtjhy; 
eff;fz;zpYs;s Kl;ilahdJ Foe;ijapd; czTg; ghijapy; 
nrd;W guTfpwJ. 
  
Neha; tUk; cz;ikAk;  mjd; vz;zKk; : 
“jhapD}z; tpidahy; gUF ePuhy; 
 jZntg;Gg; nghUs; jPq;fhy; cah; Fw;wj;jhy; 
 NrapDe;jp tsh;fhy;fs; Koq;fpj; Njq;fp 
 nropj;J tUthk; krwp NehAUf;fs; Njhd;wp 
ehapDle;J}rg;gha; mae;J Neha;fs; 
 ead;W tUk; Ez;krwp kQ;rs; ntz;ik 
 NgapDUj;jPq;F fUkrwp nfhOfyhFk; 
 ngUikAzh; ,Wjp Neha; kwypjhNd     
     Mjhuk; : Fk;gKdp ghythflk; 
       gf;f vz;:197 
fpUkp Nuhfq;fspd; nghJf;FwpFzq;fs; fPNo Fwpg;gplg;gLfpwJ> 
mitahtd: 
 njhg;Gis Rw;wp typ 
 tapW cg;Grk; 
 J}f;fj;jpy; jd; gy; fbj;Jf; nfhs;sy.; 
 %f;fpy; Gz; cz;lhjy;. 
 %f;fpYk; Mrd gFjpapYk; mhpg;G> the;jp> Ruk;> khh;G Neha;> 
Ritapd;ik> nrhpahik> fopr;ry; Mfpa FwpFzq;fs; fhZk;. 
 rpy Ntis nghpa ehf;Fg;G+r;rpfs; czTf;Foy; topahf Nky; 
Nehf;fp njhz;iltiu nrd;W the;jp nra;aKbahjthW Rthrf; 
Foy; ehrpj;Jthuq;fs; ,tw;wpy; Eioe;J milj;J 
Foe;ijfSf;F kuzj;ij cz;lhf;Fk.; 
  ,t;tpj kuzq;fs; ngUk;ghYk; Foe;ij J}f;fj;jpy; ,Uf;Fk; 
NghJ NeUk;. 
 Foe;ij cz;Zfpd;w Mfhuj;jpy; cs;s rj;Jf;fis ,it 
jpd;W tsh;tjhy; Foe;ijfSf;F td;ik Fiwe;J ntSg;G 
(ghz;L) NehAk; mjid njhlh;e;J Cjy; NehAk; tUk.; 
 Njhypy; ntz; Gs;spfs; Vw;gl;L Njhypd; epwk; khwy;> jbg;G> 
mhpg;G> jpdT> nrhhp> rpuq;F Kjypad cz;lhFk.; 
 J}f;fj;jpy; gw;fisf; fbf;Fk; J}q;Fk; NghJ fz;fs; KOikahf 
%b ,Uf;fhJ. 
 fz;fspy; mjpf gPis Njhd;Wk.; rpy Neuk; czit tpUk;gp 
cz;zhJ. 
 
         Mjhuk; : gps;is gpzp kUj;Jtk; 
        gf;fk; vz; -88>89 
kriu GO Neha; FwpFzk ; : 
NrhUQ; rPj kye;jz;zPh; 
Jyq;f tplhk Nyfope;J 
NrW kyk;Ngh yghdj;ijr; 
Nrh;j;jy; ntspapy; tapw;wpNdha; 
fhhpdpwk; Nghy; fj;jhpf;fha; 
frq;fy; Nghyf; fope;J Fj;jy; 
thUk; tlKe; jpfo; %iyaha; 
kriu GOtpd; FzkhNk 
nghUs;: 
 Foe;ij Nrhh;e;J fplj;jy; 
 xU Ntis rPjkhfTk;> xU Ntis kykhfTk;> xU Ntis 
ePuhfTk;> xU Ntis fye;jjhfTk; fopjy; 
 frq;fpd epwkha; fopjy; 
 
    Mjhuk; : Foe;ij kUj;Jtk; ghythflk; 
          gf;f vz; - 610 
 NkYk;> kriu GO Nehapd; tiffs; xd;whd Ez;krwp Nehapd; 
FwpFzkhtJ. 
czTfs; ghy;ePh; Njq;fp cg;gpr kpFjpAw;W 
 jZTW kyKQ;rPOk; jf;fhsp tpiuePh; Nghd;Wk; 
epzKW nra;ifAw;W epd;wpilapilNa NghFk; 
 mZTWTe;jp nehe;J mah;jiy Gwq;fhy; ePuhk; 
 
ePujha; kytha; js;sp epd;wpU fz;fs; %Lk; 
 rPujha; Nkdpthb jpzwpNa mOJ fhl;Lk; 
tPukha; gy;fbf;Fk; tpiue;J ePh; ghAk; %f;fpy; 
 fukhkP nul;Ls;spy; fod;W E}z; krwp NehNa 
 
nghUs; : 
  cz;Zk; ghy;> ePh; Mfpait tapw;Ws;NsNa jq;fp tapW 
cg;gprk;     cz;lhjy;. 
 kykhdJ rPjj;Jld; jf;fhspia fiuj;j ePh; Nghd;W 
ntspNaWjy;. 
 tapw;Wtyp> mah;T> Gwq;fhy;fspy; tPf;fk; Mfpad cz;lhFk;. 
 NkYk; mstpw;F mjpfkhf mbf;fb kyk; fopg;gjhy; 
Mrdtha; ntspj; js;Sk;. 
 cly; thLk;> tha; XahJ mOjy;> gy; fbj;jy; %f;fpy; ePh; 
gha;jy;> Ruk; Mfpa FwpFzq;fs; cz;lhFk; 
2. ntz;krwpapd; FwpFzk ; 
 “fz;KfKk; cly;tpswp kpfTk; Nrhh;e;J 
  fLk; typahKldOJ ,ilapilNa tpl;L 
 cz; nghUshq; fj;jphpf;fha; gpire;j ePh; Nghy; 
  cah; rPjkyk; NghYk; ntz;ikG+z;L 
 tz;kyNa tapWfope;J kytha; jhDk; 
  tUj;jKld; Gwe;js;sp tphpe;J NghFk; 
 gz;ghL Fiwe;J kpf TjLyh;e;J 
  gUf KjKzT nfhs;s ntz;krwp NehNa 
 nghUs;: 
 fz;> Kfk;> cly; ntspwp kpfTk; Nrhh;e;J fhzg;gLk; 
 kpfTk; typAld; tpl;L tpl;L mOk; 
 fj;jhpf;fha; gpire;j ePh; Nghy; kyk; fhzg;gLk; 
 tapW kpfTk; fope;J kytha; ntspj;js;Sk; 
 cjL cyh;e;J> czT cz;zhky; ,Uf;Fk;. 
 
3.kQ;rs; krwpapd; FwpFzk; 
 “tapW Gilj;J typkQ;rpf; FUjp rPoha; 
  tUQ;rspAk; kQ;rs; epw ePUk; rhAk; 
  Jah; kpFthk; ePh; fopaj;Jyq;Fk; gps;is 
  JLf;fhf mywp kpfj;jiyAe;jhOk; 
  cah; ngUk; gPfop Ntis %ye;js;Sk; 
  cWglq;fhy; tPf;fKwpypU ehd;Fs;Ns 
  mah;r;rpAWk; Gyhy; thil ff;fy; tpf;fy; 
  mZfpLfpy; kQ;rnsDk; krwpahNk 
nghUs;: 
 tapW Gilj;J kpfTk; typj;J fhZk;. 
  FUjp rPoha;> kQ;rs; epw ePWk; fhzg;gLk;.  
 kpFe;j JaUld; ePh; fopAk;.  
 gps;is kpfTk; mOJ jiy jhOk;. 
 %yk; js;sp fhZk;> fhypy; tPf;fk; cz;lhFk;>mah;r;rp 
cz;lhFk;.  
 Gyhy; thil> tpf;fy;> the;jp fhzg;gLk;. 
 
4.fU krwpapd; FwpFzk;: 
  “fUkrwpAw;w kfTlYthb 
  fz;%f;F Nky; tpah;j;J itj;Jsp frpe;J 
 cUfUfp tapW Fj;jp typj;Jise;J 
  T+z; RUq;fpAly; fwpNghy; kyq;fope;J  
  gU%ykha; tphpe;J fUk;GOf;fs;  
  gw;wpNa rPo; FUjp frpe;J ehwp 
 tUKW fy; jZg;gpSg;G Nfhio ghAk; 
  tUe;jpaPuhw; jhz;bLfpy; kPSnkd;Nwd;” 
nghUs;: 
 kftpd; cly; thb fz;> %f;fpd; Nky; tpah;j;J Jspaha; frpAk; 
 tapW Fj;jp typj;J cisAk;. Cz; RUq;Fk;. 
 fwpNghy; kyq;fopAk;. fUk; GOf;fs; ntspg;gLk; 
 rPo;> FUjp frpe;J ehWk;. ,Og;G> Nfhio ntspg;gLk;. 
5. nfhOfy; krwpapd; FwpFzk;: 
“nfhOfp tUk; Kl;Nghd;w fhl;rp naa;Jk;  
  Flw;Njhw;Wk; nfhOfy; Ez;GOT jhDk; 
tOtOj;Jf;Fly; Fj;jp FUjp rpe;jp  
  tUj;jKW typNjhd;wp kjiy jd;id 
KOg;ghf %r;rplwp Kfq;fdj;J 
  Kof;fKld; kyq;fope;J mywpr;rPwp 
gOg;ghf ntsp fz;L %ye;js;Sk; 
  gw;wpNa As;thq;fhJod;W fhZk; 
 
“fhZNk fha;r;ry; ntwpAg;gprq;fs;  
  fLj;J ePh; tpLk; NghJ myWk; gps;is 
GZtha; gy; G+l;Lk; KWfYz;lhk; 
  Gz;zhff; Fly; fhZk; nghypAk; td;ik 
NjhZNk Aly; kyKq; fjpj;Jf; fhZk;  
  njhFjpAwpy; ,U%d;W ehspw; nfhy;Yk; 
NgZjyha; clYapUe;Jbj;Jr; rPwpy; 
  ngUikAW ehq;nfhd;wpy; kwyp G+Fk;” 
nghUs;: 
 Flypid Fj;jp FUjp rpe;jp typ Njhd;Wk; 
 %r;R tpl rpukk;> Kfk; fdj;J fhZk;> kyk; rj;jj;Jld; 
ntspg;gLk; 
  %yk; gOg;G epwkha; ntspj;js;Sk; 
 fha;r;ry;> cg;gprq;fs; fhzg;gLk;. ePh; nry;Yk; NghJ Foe;ij 
mOk;. 
 gy; ,WFk;. Flypy; Gz; Vw;gLk;. cly;> kyk; fjpj;J fhZk;. 
,uz;L> %d;W ehspy; nfhy;Yk;. 
      Mjhuk;: kjiy Neha; njhFjp- I 
           gf;f vz; 377-380 
 
kriug;GOtpd; FwpFzk ;: 
 kyk; fUfp epd;W Fjthapw; Fj;jpf; FKwp FUjp tpOk;. kyj;Jld; 
rPjQ; rpjwpf;fhZk;  cjg;ig js;Sk;. fPo;tapWise;J NehFk;. 
     Mjhuk;: Mj;kul;rhkph;jnkd;Dk; 
              itj;jpa rhurq;fpufk; 
                 gf;f vz;:142 
 
Kf;Fw;w ,ay;:- 
 thjk;> gpj;jk;> fgk; Mfpa %d;Wk; caphjhJf;fs; vdg;gLk;. ,it 
jd;dpiyapy; khwpnray;gLk; Neuj;jpy; clypy; Neha; epiy Vw;gLfpwJ.  
 Flw;fpUkp - kriuGO NehahdJ gpj;jk; my;yJ fgj;jpd;  
Mjpf;fj;jpdhy; Vw;gLfpd;wJ. NkYk; czthjpnray;fshy; cz;lhfpwJ. 
vdNt ,e;Nehapy; gpj;jkhdJ Kjypy Nflile;J gpd;dh; fgk; Nflile;J 
mjNdhL thjj;ij Nflilar;nra;J Nehapid cz;lhf;FfpwJ.  
 ‘cw;wNjhh; clypy; $W 
   cWg;Gld; tputp epd;W 
  Kw;WNk Neha;fs; vy;yhk; 
   Kjy;jdpy; Njhd;Wk; NghJ 
  Gw;WNk thj gpj;j 
   rpNyw;gde; jd;dpy; xd;iwAk; 
  gw;wpNa Njhd;Wk; vd;W 
   gfh;e;jdh; Kdpth; jhNk” 
      -mfj;jpah; FUehb  
 caph; jhJf;fs;  
thjk; thOkplk;:-  
 mghdd;> kyk>; ,lfiy> ce;jpapd; fPo;%yk;> fhkf;nfhb> Cd;> 
,Lg;G vYk;G> Njhy;> euk;G $l;lk;> fPy;fs;> kaph;f;fhy;fs; 
thjk; ,aw;if gz;G:-  
  tspahdJ jd; ,aw;if epiyapy; Cf;fKz;lhf;fy;> %r;R 
tply;> %r;R thq;fy>; kdnkhop nka;fSf;Fr; nraiyj; juy;> kyk; Kjypa 
gjpdhd;F Ntfq;fis ntspg;gLj;jy;> rhuk; Kjypa VO clw; 
jhJf;fSf;Fk; xj;j epfo;r;rpiaj; juy; Ik;nghwpfl;L td;ik nfhLj;jy; 
Mfpa nray;fis nray;gLj;jp clYf;F Jiz GhpfpwJ. 
thjk; clypy; nra;njhopy;  
 cly;Nehjy;> Fj;jy;> kyk;> rpWePh; Kjypd jPa;jy; my;yJ  
milgLjy; cWg;Gj; jsh;r;rp> ePh;Ntl;if> ePh;g;girapd;ik vr;RitAk; 
Jth;g;ghapUj;jy; if fhy;fis ePl;lTk;> klf;fTk; Kbahik 
kaph;$r;nrwpjy; nfz;ilf;fhy> njhil Kjypad nehWq;fpg; NghtJ 
Nghyj; Njhd;wy;> cly; ,isj;jy;> Filr;ry; Mfpad thjk; 
clypy;nra;Ak; njhopy;fs;  
 
thjj;jpd; gphpTfs;:-  
1. gpuhzd;: 
 Flw;fpUkp Nehapy; gpuhzd; ,ay;G 
2. mghdd;:  
 ,J Rthjpl;lhdj;jpy; ,Ue;J ntspg;gl;L fPo;Nehf;fp kyryj;ij 
js;Sk;. Mrdthia RUf;Fk;. md;drhuj;ijr; Nru Ntz;ba ,lq;fspy; 
Nrh;g;gpf;Fk; 
 Fly;fpUkp Nehapy; kyf;fl;L> fpUkp kyj;jpy; fye;J ntsptuy; 
fopr;ry;Mfpad Vw;gLtjhy; mghdd; ,af;fj;jpy; ghjpg;G Vw;gLk;.  
3. tpahdd;:  
 ,J Njhypy; ,Ue;J vOgj;J ,uz;lhapuk; ehb euk;G ,uj;j 
Foha;fspYk; nrd;W ,t;TlypYs;s mirAk; nghUs;> mirahg; nghUs; 
vd;Dkpuz;bypUe;J cWg;Gfis ePl;lTk; klf;fTQ; nra;J ghprq;fis 
 mwpAk;.  cz;Zk; cztpd; rhuj;ij  mt;tplq;fspy;  epug;gpj;J cliyf; 
fhf;Fk; 
 Flw;fpUkp Nehapy;  cly; KOikAk; jpdTk;> typAk; Vw;gLtjhy; 
tpahdd; ,af;fj;jpy; ghjpg;G Vw;gLk;.  
 
4. cjhdd;:  
 ,J cjuhf;fpdpapy; ,Ue;J Njhd;wp  cztpd; rhuj;NjhL 
$bapUe;J mij mq;fq;Nf epWj;Jk;. mij ntspg;gLj;jpAk; fyf;fpAk; 
tUjy; nra;Ak; 
 Flw;fpUkp Nehapy; tha;Fkl;ly;> the;jp Vw;gLjthy; cjhdd; 
,af;fj;jpy; ghjpg;G Vw;gLk;. 
5. rkhdd;: 
 ,J ehgpapypUe;J fhy; tiuf;Fk; rkdha; gutpg; gha;e;J 
mWRitfisAk;> jz;zPh; md;dk; Mfpat;wiwak; rkg;gLj;jp 
clypnyy;yhk; NrUk;gb nra;Ak;.  
  Flw;fpUkp Nehapy; grpapd;ik Vw;gLtjhy; rkhdd; ,af;fj;jpy; 
ghjpg;G Vw;gLk; 
6. ehfd;:  
 Flw;fpUkp Nehapy; ehfd; ,ay;G 
7. $h;kd;: 
 ,J kdjpypUe;J fpsk;gpf; fz;zpypUe;J ,ikiaf; nfhl;Ltpf;Fk;. 
nfhl;lhtp tplg;gz;Zk;.  Flw;fpUkpapy; Jhf;fkpd;ik Vw;gLk; vdNt 
$h;kd; ,af;fj;jpy; ghjpg;G Vw;gLk;.  
8. fpUfud ;:  
 ,J ehtpypUe;J fpsk;gp Ritapid mwpar; nra;Ak.;  
 Flw;fpUkp Nehapy;  grpapd;ik Vw;gLjtjhy;  fpUfud; ,af;fj;jpy; 
ghjpg;G Vw;gLk;  
 
 
 
 
 
 9. Njtjj;jd;:  
 Flw;fpUkp Nehapy; Njtjj;jd; ,ay;G. 
czthjp nray;fspd; Ngjk;. 
 
        Kf;Fw;wk; miljy; 
 
 
gpj;jk;           fgk;    thjk; 
 
mdw;gpj;jk; (nrhpahik)     fpNyjk;    mghdd; - kyf;fl;L>                                  
;                                           (nrhpahik)                         fopr;ry; 
,uQ;rfg;gpj;jk; 
(nre;ePh; FiwT)              tpahdd; - cly;Nrhh;T 
gpuhrfg; gpj;jk;        cjhdd; - the;jp 
(Njhypy; jbg;Gfs;>       rkhdd; - Cz;ntWg;G 
 Njhy; twsy;)                $h;kd; - Jhf;fkpd;ik 
rhjfg;gpj;jk;             fpUfud; - Rit khWghL 
(cly; Nrhh;T) 
 
moy; ( gpj;jk;)  
gpj;jk; thOkplk;: 
 ‘gphpe;jpLk; gpj;jk; NguhQ;ryj;jpdpy;” vdj; jpU%yUk;  
  Nghnkd;d gpj;jj;Jf;fpUg;gplNk Nfsha; 
 Nguhd fz;lj;jpd; fPojhFk; -vd A+fp  KdptUk; 
    
moypd; ,aw;ifg; gz;G: 
 moyhdJ jdJ ,aw;if epiyapdpd;W nrhpg;gpj;jy>; ntk;ik> 
ghh;it> grp> ePh;> Ntl;if> Rit. xsp> epidg;G> mwpT> td;ik> nkd;ik 
vd;gdtw;iw cz;lhf;fp clw;Fj;Jiz GhpAk;  
 
 
 moypd; gphpTfs;:  
1. mdw;gpj;jk;: 
 Fly;fpUkp  Nehapy; grpapd;ik> nrhpkhd NfhshW Vw;gLtjhy; 
mdw;gpj;jk; ghjpg;G Vw;gLk; 
2. ,uQ;rf gpj;jk;: 
 Flw;fpUkpfs; ntSg;G Nehia Vw;gLj;Jtjhy; ,uQ;rf gpj;jk;  
ghjpg;G Vw;gLk;. 
3. rhjfg; gpj;jk:; 
 Flw;fpUkp Nehapy; clw;Nrhh;T Vw;gLtjhy; rhjfgpj;jk; ghjpg;G 
Vw;gLk; 
4. MNyhrf gpj;jk;:  
 Flw;fpUkp Nehapy; MNyhrf gpj;jk; ,ay;G 
 
5. gpuhrf gpj;jk;: 
 Flw;fpUkp Nehapy; ntSj;j epwg;gilfs;> mhpg;G> jbg;Gfs; 
cz;lhtjy; gpuhrf gpj;jk; ghjpg;G Vw;gLk;.  
fgk; ,aw;if gz;G: 
 fgk; jd; ,aw;if epiyapy; epiyj;jy>; nea;g;G fPy;fspd; mikg;gpd; 
fl;Lfs; nghiwAilik mjhtJ grp> ePh; Ntl;if> Jauk; fyf;fk;> ntg;gk; 
,itfis nghWj;Jf; nfhs;Sjy; Mfpa ,itfs; fgj;jpd; ,aw;if 
gz;Gfs;  
fgk; gphpTfs;:  
1. mtyk;gfk;: 
 Flw;fpUkp Nehapy; mtyk;gfk; ,ay;G 
2. fpNyjfk;: 
 Flw;fpUkp Nehapy; tapw;wpy; typ cz;lhFk; mjdhy; fpNyjfk; 
ghjpg;G milAk;  
3. Nghjfk;:  
 Flw;fpUkp Nehapy; Nghjfk; ,ay;G 
4. jw;gfk;:  
 Flw;fpUkp Nehapy; jw;gfk; ,ay;G 
 
 5. re;jpfk;:  
 Flw;fpUkp Nehapy; re;jpfk; ,ay;G  
 
VO cly; jhJf;fs; 
1. rhuk;: 
 Fly;fpUkp Nehapy; cly;Nrhh;T Vw;gLk;. MfNt rhuk; ghjpg;gilAk;  
2. nre;ePh;: 
 Fly;fpUkp Nehapy; cly; epwk; Fiwjy;> twl;rp Vw;gLk;> nre;ePh; 
 ghjpg;gilAk;. 
3. Cz;:  
 Fly;fpUkp Nehapy; Cz; ,ay;G 
4. nfhOg;G 
 Fly;fpUkp Nehapy; nfhOg;G ,ay;G 
5. vd;G:  
 Fly;fpUkp Nehapy; vd;G ,ay;G 
6. %is 
 Fly; fpUkp Nehapy; %is ,ay;G 
7. Rf;fpyk; / RNuhzpjk;: 
 Fly; fpUkp Nehapy; Rf;fpyk;/ RNuhzpjk; ,ay;G 
gpzpawpKiwik:  
 gpzpawpKiwik vd;gJ cliyg; gpzpj;jyha; Nehiaj; njhpe;J 
nfhs;Sfpw xOf;fk; vdg;gLk;. ,it %d;W tifg;gLk; 
  
1. nghwpahywpjy; 
2. Gydhywpjy; 
3. tpdhjy; vd;Dk; tpjpfisAk; mtw;iwj; Jizahfg; gw;wp xOFk; 
xOf;fq;fisAk; Fwpf;Fk; 
 
I  nghwpahywpjy;  
  %f;F  -  ,ay;G 
  eh   - ,ay;G 
   fz;   - ,ay;G 
 Njhy;   - ntSj;j epwg;gilfs; fhzg;gLk;  
 nrtp   - ,ay;G 
 
II. Gydhywpjy ; 
 ehw;wk;  - ,ay;G 
 Rit   - ,ay;G 
 xsp   - ,ay;G 
 CW   - ,ay;G 
 Xir   - ,ay;G 
 
III  tpdhjy;: 
  tpdh vd;gJ Nfl;lwpjy;> tpdhjy; vd;gJ 
gpzpAw;Nwhdplj;Jk;>gpzpjPh;Nghdplj;Jk; cs;s nghwp Gyd;fs; 
gpzpfisj; njspthAzh;j;Jkhifahy; kUj;Jtd;jd;id Nehf;fp te;j 
gpzpAw;wtid gw;wp mwpa Ntz;batw;iw mwpe;Jk; jd; nghwp Gyd;fshy; 
gpzpahsDila nghwp> Gyd; topaha; czh;tij Nfl;Lk; mtd; xUf;fhy; 
vf;fhuzj;jpdhNy jhd; Nfl;lijr; nrhy;Ytjw;fpayhjtdhapUg;gpd; 
mtd; Rw;wj;jhiuf; nfhz;L mwpaf; $batiu mwpe;Jk; gpzpiaf; 
fzpj;jiyg; gw;wpNa Fwpf;Fk;.  
cly;  td;ik 
cly; td;ik 3 tifg;gLk; 
1) ,aw;if td;ik 
 ,J rj;Jt> uNrh> jNkh Fzq;fspdpd;Wk; ,aw;ifahfNth 
cz;lhtjhk; Fly; fpUkp Nehapy; ,aw;if td;ik ghjpf;Fk; 
II) nraw;if td;ik 
 clw;fl;Lfspy; td;ik nflh tz;zk; epiy epWj;jf;$ba 
kUe;JfhsYk;> fhj;J nfhs;tjhy; cz;lhtjhk; 
III) fhy td;ik 
 ,J Mz;lhYk; (tajhYk;) ,sNtdpy; Kjypa ngUk;nghOjhYk; 
cz;lhtjhk;> Fly; fpUkpapy; fhy td;ik ghjpg;G 
  fhh;fhyk;  - Mtzp> Gul;lhrp (August, September) 
 $jph;fhyk;  - Ig;grp> fhh;j;jpif (October, November) 
 Kd;gdpfhyk; - khh;fop> ij (December, January) 
 gpd;gdpfhyk; - khrp> gq;Fdp (February, March) 
 ,sNtdpy; fhyk; - rpj;jpiu> itfhrp (April, May) 
 KJNtdpy; fhyk; - Mdp> Mb (June, July) 
 thjk;> gpj;jk;> fgk; Mfpad jd;dpiy tsh;r;rp> Ntw;Wepiy 
tsh;r;rp>  jd;dpiyailAk; fhyk; 
Fw;wq;fs; 
jd;dpiy 
tsh;r;rp 
 
Ntw;W epiy 
tsh;r;rp 
jd;dpiy 
thjk; KJNtdpy; fhh;fhyk; $jph; fhyk; 
gpj;jk; fhh;fhyk; $jph; fhyk; Kd;gdp fhyk; 
fgk; gpd;gdpf;fhyk; ,sNtdpy; KJNtdpy; 
 
Itif epyq;fs; 
 Itif epyq;fspy; trpg;gth;fSf;F cz;lhff; $ba Neha; epiyfs; 
1. FwpQ;rp  (kiy rhh;e;j ,lk;) 
  ,uj;jk; cwpQ;Rk; Ruk;> tapw;wpy; Mikf;fl;b cz;lhf;Fk;.
 rpNyj;Jkk; jq;Fk;. 
2. Ky;iy (fhL rhh;e;j ,lk;) 
  thj Neha; cz;lhFk;. 
3. kUjk; (tay; rhh;e;j ,lk;) 
  Kj;Njhl Neha;fis Nghf;Fk;. 
4. nea;jy; (fly; rhhe;j ,lk;) 
  nkype;j cliyg; gUf;fr; nra;Ak; <uiyg; ngUf;Fk;> 
 nfhLikahd thjNeha; cz;lhFk;> Fly;thA cz;lhf;Fk;. 
5.  ghiy (kzy; rhh;e;j ,lk;) 
  thjk;> gpj;jk;> fgk; ,tw;wpy; tpisfpd;w gpzpfl;F ,Ug;gplk;. 
 
 
 vz;tifj; Njh;T 
 gpzp mwpAk; Kiwapid kUj;Jt mwpQh;fs; vz;tifaha; 
tFj;Js;sdh; 
   ‘ ehbg;ghprk; ehepwk; nkhoptpop 
     kyk; Kj;jpukpit kUj;JtuhAjk;” 
i) ehb 
 thjnkd;Dk; ehbaJ Njhd;wpy; 
  rPjke;jnkhL tapW ngUky; jpul;rpthA 
 rPj KWq;fpuhzp kNfhjuk; ePuhik 
  jpusthA #iy typfLg;Gj; jPiu 
 ePj KWq;fp Ukp Fd;kk; mz;lthjk; 
  epiyAk; ePh;f; fphpr;ruq;fs; je;JNkfk; 
 Ngjfkh Kjugpzp %yNuhfk; 
  Ngr ntF gpzpfSNk nghUsjhNk 
         rjf ehb 
ii) ];ghprk; 
 kpj ntg;gkhf fhzg;gLk; 
iii) eh 
 ntSj;J>  khgbe;jJ Nghy; fhzg;gLk; 
IV) epwk; 
 ntSj;j epw gilfs; fhzg;gLk; 
V) nkhop 
 ,ay;G 
vi) tpop 
 ,ay;G 
vii) kyk; 
 kykhdJ ,WfyhfNth my;yJ ,sfhyhfNth fhzg;gLk;. 
 kyj;jpy; GOf;fs; fhzg;gLk;. 
Viii) %j;jpuk; 
 ,ay;G 
 
 ePh;Fwp 
 epwk;  - ,sk; kQ;rs; 
 kzk ; - ,ay;G 
 vil  - ,ay;G 
 Eiu  - ,y;iy 
 vQ;ry; - ,y;iy 
nea;f;Fwp 
 thj ePh; my;yJ gpj;j ePh; fhzg;gLk; 
kyf;Fwp 
 epwk;  - ,ay;G 
 kzk;  - ,ay;G 
 ,Wfy; - cs;sJ 
 ,sfy; - ,y;iy 
 
kUj;Jtk; 
gj;jpak; 
 Flw;fpUkp Nehapy; ghjpj;j Foe;ijfSf;F cly; rj;jw;W ,Uf;Fk;. 
vil Fiwe;J fhzy;> ntSg;G Neha; Nghd;w FwpFzq;fs; ,Ug;gjhy; 
mtw;iw jtph;f;f 
 i)  ,Uk;G rj;J epiwe;j czTfs; 
 ii) Guj rj;Jfs; czTfisAk; fha;fwpfs;> fPiufs; cz;z  
  Ntz;Lk; 
 Flypy; kpFe;j msT ngUfp tsh;e;Js;s GOf;fis 
ntspNaw;Wtjw;Fk; gpwF mjd; fhuzkhf tUfpd;w Jiz 
Neha;fSf;Fk; kUj;Jtk; nra;a Ntz;Lk;.NkYk; Flypy; GOf;fs; 
cz;lhfhky; ,Uf;f kUe;JfSk; jf;f MNyhridAk; toq;f Ntz;Lk;. 
 Flypy; GOf;fis mfw;w GOf; nfhy;yp nra;ifAk;> kykpsf;fp 
nra;ifAk; nfhz;l kUe;Jfisf; nfhLj;J GOf;fisAk; mjd; 
Kl;ilfisAk; kyj;Jld; ntspNaw;w Ntz;Lk;. 
 
 
 mwpTiu 
1. mRj;jkhd ePiu gUff;$lhJ. 
2. J}a;ikaw;w czT> fha;fwpfs;> goq;fs; cz;gij jtph;f;fNtz;Lk;. 
3. nfl;L Nghd japh;> gioa rhjk;> mOfpa fha;fwpfs;> goq;fs; 
jtph;f;fTk;. 
4. J}a;ikahd Milfis mzpa Ntz;Lk;. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MODERN ASPECTS 
GIARDIASIS 
INTRODUCTION : 
 Helminthiasis also known as worm infection a parasitic disease of humans 
and other animals in which a part of the body is infected with parasitic worms 
known as helminths. There are numerous species of these parasites, which are 
broadly classified into tapeworms, flukes, and roundworms.  They often live in the 
gastrointestinal tract of their hosts, but they may also burrow into other organs 
where they induce pathology damage. 
 Helminthiasis has been found to result in poor birth outcome, poor 
cognitive development, poor school and work performance, poor socioeconomic 
development and poverty. Chronic illness, malnutrition, and anaemia are futher 
examples of secondary effects. 
HELMINTHIC INFESTATIONS : 
 Helminthiasis is caused by three groups of worms 
 Nematodes (roundworms) 
 Trematodes (flukes) 
 Cestodes (tape worms) 
 These organisms differ markedly in their life cycle, mode of infections and 
pathogenesis. 
PARASITIC INFESTATION : 
 It has been estimated  that, worldwide there are 1-2 billion episodes of 
toxoplamosis, one billion episodes of infestation due to Ascaris lumbricoides 
(round worm), 800-900 million episodes of bookworm infestation, 200-400 
million episodes of amoebiasis, 200-300 milllion episodes of schistosomiasis and 
malaria, and 200-250 million episodes of filarias is and giardiasis in a single year 
certainly, parasitic diseases occur most frequently in developing countries, perhaps 
due to generally inadequate standards of sanitation. We should note, however, that 
such diseases often without clinical symptoms, occur even in developed countries 
maintaining high sanitary standards; infact, parasitic diseases are being recognized 
 with increasing Frequency in North America and Europe, especially in immune 
compromised patients. 
 The most striking difference between parasites and other infectious agents 
is the variety of host vectors and stages in their life cycles.  Knowledge of the life 
cycle is important since this provides important  clues to understanding the parasite 
diseases and helps in diagnosis and in the development of public health strategies. 
 Several parasitic diseases of humans are  infact, zoonoses (caused by agents 
that usually infect other mommats, birds or reptiles).  Sometimes, the parasites  
require both humans and animal to complete their lifecycles (eg: the 
developmental cycle of Taenia saginata, the beef tapeworm, requires both humans 
and animals become infected).   In other instances the parasite accidentally infects 
humans and then is unable to complete its development, the human becomes a 
‘dead – end – host’ for it. 
 Not all infections by parasites end in disease, that is , the host may harbour 
the parasite but may not suffer from any symptoms; this may occur if the parasite 
is present in small numbers.  Severity of infection depends on agent factors such as  
the number of parasites causing the infection and host factors such as the age, sex 
and the race of the host. 
 Many becteria and viruses cause acute illnesses.  Similarly, some parasitic 
diseases may be aute and life threatening even in normal healthy persons or in 
immunocompromised individuals. 
 However, most parasitic diseases tend to be more chronic and there in lies 
the danger.  They may cause little damage to the host in the beginning, and may be 
more of an inconvenience, so that the infected individual does not seek treatment.  
However, if left untreated they gradually lead to harmful effects, such as anemia, 
fever or pruritis in the host. 
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 CLASSIFICATION OF PARASITES : 
 
 
  
 
 
 
 
 
 
 
 
GIARDIASIS : 
 Giardiasis, caused by Giardia lamblia (also known as G.intestinalis or 
G.duodenalis)  is a major cause of diarrhea in children and in travelers.  Giardia 
lamblia has a worldwide distribution and is often the etiologic agent of out breaks 
of gastroenteritis and travelers diarrhea.  It is the most commonly reported 
intestinal protozoa in the united states.  The main groups at risk for infection are 
travelers returning from endemic areas, hikers who drink untreated water from 
streams, and children in day care centers.  Travelers are often enposed to 
conditions in which water borne or food – borne cysts are ingested due to poor 
sanitation.  However, cysts are resistant to chlorination and out breaks have been 
reported from fecally contaminated swimming pools. 
 Animals such as the beaver may serve as reservoirs and may be a source of 
infection for backpackers, who drink from streams or rivers.  The names ‘beaver 
fever’ or ‘backpacker’s diarrhea’ have been used to describe the condition in this 
group of people.  Children younger than 5 years of age are at particular risk for 
infection and G.Lamblia has caused outbreaks of  diarrhea in nurseries and daycare 
centers as a result of person to person contact.  Along with E.histolytica, G.lamblia 
among those who practice oral – anal sex. 
PARASITES 
Protozoa Helminths Arthropods 
Nemathelminths Platyhelminths 
Trematodes Cestodes 
  Giardia was first seen by leeuwenhuek in 1681 while examining his own 
stools.  Most Giardia infections are a symptomatic. 
CLASSIFICATION OF GIARDIA 
 Phylum  : Protozoa 
 Subphylum : Plasmoderma 
 Class   : Mastigophora 
 Order  : Diplomonadida 
 Genus  : Giardia 
HABITAT 
 The organism is present in the duodenum and upper part of ileum.  This 
flagellate inhabits the duodenum and the upper part of the jejunum in humans.  
Incidence of Giardia lamblia varies with age.  It is most common in children but 
frequency in adultls is appearently increasing in recent years. 
STRUCTURE: 
The Giardia life cycle involves two stages. 
  The trophozotie  
 The cyst 
 The Giardia lamblia trophozoite is easily recognized under a microscope.  It 
is about 12 to 15 um long, shaped like tennis racket.  The dorsal surface is convex 
and the ventral surface is concave with a sucking disc, and has two nuclei that 
resemble eyes, structures called median bodies  that resemble a mouth and four 
pairs of flagella that look like hair; these combine to give the stai ned trophozoite 
the appearance of the face.  The flagella help these organisms to migrate to a given 
area of the small intestine, where they attach by means of an adhesive disc to the 
epithelial cells and thus maintain  their  position  despite peristalsis.  It is 
bilaterally symmetrical.  The anterior end broad and the posterior end tapers to a 
sharp point. 
EPIDEMIOLOGY : 
 The infection is endemic in developing countries with poor sanitation.  
Individuals with malnutrition, humoral immunodifiencies and cystic fibrosis are 
particularly  susceptible.  Children appear to be more severely affected than adults. 
  
 
 
 
  
 
 
 
 LIFE CYCLE : 
 The usual natural reservoir in humans, although wild and domestic animals 
may also be a source.  The trophozoite multiples in the intestine by binary fission.  
When conditions are unfavourable, encystment occurs (usually in the intestine).  
Humans are infected when they ingest the cyst.  The trophozoites emerges form 
the cyst, multiples in enormous numbers and colonises the duodenum and often the 
Gall bladder 
 Giardia infection is acquired by ingesting cysts.  The exposure of cysts to 
host stomach acidity and body temperature triggers excystation, which is 
completed in the small intestine with the emergence of trophozoites that promptly 
attach to the host intestinal epithelium. 
 The trophozoite or the actively metabolizing motile form, lives in the upper 
two – thirds of the small intestine (duodenum and jejunum) and multiples by 
binary fission.  Trophozoites that are swept into the faecal stream lose their 
motility, round up and are excreted as dormant, resistant cysts.  The mechanisms 
that cause the signs and symptoms of giardiasis are not known. 
 Excreted trophozoites disintegrate. The cyst, although not as resistant as 
many bacterial endospores is sufficiently hard to survive host to host transfer.  For 
example some Giardia cysts excyst successfully after more than 2 months of 
storage in water and refrigerator temperatures. 
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 MODE OF INFECTION IN HUMANS : 
SOURCE :  
 Infected human, beaver, other wild and domestic animals. 
INFECTIVE AGENT : 
 Cyst in feces. 
MODE OF TRANSMISSION : 
 Faeco-oral transmission. Cysts in faces are transmitted to the mouth directly 
by contaminated fingers or indirectly by contaminated water. 
PORTAL OF ENTRY : 
 Oral Cavity 
SITE OF LOCALISATION 
 Trophozoite (released from cyst) localises in duodenum and bile passages. 
ETIOPATHOGENESIS: 
 Giardia exists in two stages cysts and trophozoites. Outside the human body 
it exists in the form of cysts. Cysts are hardy, capable of surviving in cool, moist 
environment for upto 2 months and in water that has been routinely chlorinated but 
are destroyed by boiling for 10 minutes.  
 Transmission of infection is through cysts which may be ingested in 
contaminated water or food or spread by direct person to person contact. Ingestion 
of 10 – 100 cysts is sufficient for causing infection. Low PH of the duodenum 
facilitates excystation and release of trophozoites. Trophozoites colonize the 
duodenum and proximal jejunum of the host, where they attach to the intestinal 
brush border. It is believed that the infection causes diarrhea via a combination of 
intestinal malabsorption and hypersecretion. These effects cause malabsorption 
and maldigestion and in addition, may facilitate the development of chronic enteric 
disorders, including inflammatory bowel disease and irritable bowel syndrome. 
CLINICAL INFECTION:- 
 As few as 10 cysts may initiate infection with G. lamblia. The organism 
reacts to the PH in the stomach and begins to excyst. The organism then responds 
to the slightly alkaline PH in the small intestine and completes the process in the 
duodenal area where the presence of carbohydrates and bile stimulate trophozoite 
 growth. Although it does not invade the mucosal surface it does attach to the 
surface of columnar epithelial cells. Adherence to the intestinal mucosa is achieved 
by the ventral sucking disk and possibly binding by a mannose binding lectin. 
Pathologic mechanisms associated with the organism include damage to the 
mucosa, interference with absorption of nutrients, and irritation. Bacterial 
overgrowth may contribute to symptoms. There is no protozoan enterotoxin 
produced but decreased height or atrophy of the intestinal villi affects activity of 
several intestinal enzymes including trypsin and lipase. Protection from 
colonization may be achieved due to secretory IgA present on the mucosal surface 
as well as the presence of molecules such as nitric oxide. 
 In most patients the acute infection manifests as a self  limiting diarrhea 
with malaise, cramps, nausea and abdominal tenderness after an incubation period 
of 12 to 14 days. Explosive, foul smelling diarrhea is present. Symptoms last 1 to 4 
weeks and the patient may lose a significant amount of weight. Patients with 
secretory IgA deficiency or achlorhydria seem not only to be more apt to develop 
the infection but also to develop chronic infection. In chronic giardiasis there may 
be a malabsorption like syndrome with up to 20% weight loss, fatigue, anoreria, 
and steatorrhea with large amount of gas.  
CLINICAL FEATURES: 
 The incubation period after ingestion of cysts is 1 – 2 weeks. Most 
infections in both children and adults are asymptomatic. Symptomatic infections 
are more common in children than in adults and usually take the form of acute 
diarrhea with sudden onset of explosive, watesy, foul smelling stools, along with 
nausea, and anorexia, other may also have abdominal distension. 
1. Flatulence 
2. Epigatric cramps and Mild Fever 
 There is no blood or mucus in stools. The illness may last 3 – 4 days and is 
usually self limiting in normal immonocompetent children. Variable degree of 
malabsorption may occur. Some patients may have a protracted course with 
persistent or recurrent mild to moderate symptoms such as brief episodes of loose 
foul smelling stools alternating with constipation. Persistent diarrhea may be seen 
 in 30 – 50% cases. A few children may develop chronic diarrhea, lactose and fat 
malabsorption and failure to thrive. 
 
 LABORATORY DIAGNOSIS 
 This depends on detection of cysts in formed feces or trophozoites in liquid 
feces concentration methods (e.g. Formalin – either procedure). A stained 
smear should be examined. Several samples should be tested at different 
intervals since cyst production may not be continuous.  
 Trophozoites (rarely cysts) can sometimes be demonstrated by duodenal 
aspiration or the ‘string test’ or duodenal biopsy. 
Feces serve as the usual diagnostic specimen, but shedding of the cysts is 
irregular, and multiple specimens are often required for diagnosis. When clinical 
symptoms persist and the organism cannot be demonstrated in the feces a duodenal 
aspirate or the Enterotest may be used to isolate the organism. EIAs using 
monoclonal antibodies to detect soluble antigens of G.lamblia in stool have also 
been developed. Several direct fluorescents antibody kits that detect the presence 
of either G.lambliacysts or the presence of Giardiacysts are available. 
The trophozoites of G.lamblia are pear shaped bilaterally symmetric and 
measure approximately 9 to 21 by 5 to 15mm. They show a characteristic “falling 
leaf” motility in a wet mount. In a permanently stained smear the binucleate 
organism has been described as having an “old man” appearance. Two oval nuclei 
each with a large central Karyosome, are on each side of the midline. Four pairs of 
flagella midline axonemes and two median bodies posterior to the nuclei are also 
present. A large ventral sucking disk is attached to the intestinal wall.  
Cysts of G.lamblia are oval and approximately 8 to 12mm by 7 to 10mm. 
There are upto four nuclei and the cytoplasm is often pulled away from the cyst 
wall. On a permanently stained smear, the retracted flagella and other internal 
structures give the cyst a cluttered appearance.  
 
 
 
 COMPLICATIONS OF GIARDIASIS: 
 Giardia infection is almost never fatal in industrialized countries but it can 
couse lingering symptoms and serious complications especially in infants and 
children. The most common complications include.  
 DEHYDRATION: 
 Often a result of severe diarrhea, dehydration occurs when the body doesn’t 
have enough water to carry out its normal functions. 
 FAILURE TO THRIVE: 
Chronic diarrhea from giardia infection can lead to malnutrition and harm 
children’s physical and mental development. 
 LACTOSE INTOLERANCE: 
Many people with giardia infection develop lactose intolerance (the ability 
to properly digest milk sugar). The problem may persist long after the infection has 
cleared.  
 
 
EXTRA – INTESTINAL CONSEQUENCES OF GIARDIA INFECTIONS 
 Until recently, the scientific literature rarely reported extra – intestinal 
manifestation in giardiasis.  
OCULAR PATHOLOGIES: 
 The first description of ocular complications in patients with giardiasis was 
made by Barraquer who reported cases of iridocyclitis, choroiditis and retinal 
haemorrhages in patients that presented diarrhea linked to the presence of Giardia. 
More recent observations described a “salt and pepper” degeneration (Punctuate 
areas of normal hyperpigmentation on a light yellow pink – retina) involving the 
retinal pigmented epithelium in children suffering from giardiasis.  
ARTHRITIS: 
 Inflammatory arthritis has also been described following enteric infections 
with the organism such as Giardia sp, Brucella sp. 
 
 
 ALLERGIES: 
 In a recent study in children, giardiasis was associated with an increase in 
total serum immunoglobulin E (IgE) levels and an enhanced IgE antibody response 
to common allergens. 
GENERAL PREVENTION METHODS: 
 Effective control measures are potentially available for all parasitic 
diseases. The most effective measures seek to disrupt the mode of transmission of 
the parasitic diseases and to interrupt the parasites life cycle. Sometimes drugs 
may be used to prevent a person from becoming infected (chemoprophylaxis), for 
example chloroquine for persons entering areas where malaria is prevalent. 
Treatment regimens for parasitic infections are generally not efficient in 
controlling the disease due to long delay between infection and clinical 
presentation; treatment is usually given to prevent the systemic complications of 
chronic infection or to relieve acute complications. Since many important parasites 
survive and produce disease because they are able to evade the host immune 
response it has been difficult to develop effective vaccines for such diseases. In 
recent years, however efforts have been intensified to develop vaccines for 
malaria, schistosomiasis, onchocerciasis, lymphatic filariasis and toxoplasmosis. 
PREVENTION FOR GIARDIASIS: 
 There is no vaccine to prevent giardia in humans nor any recommended 
chemoprophylaxis. 
 Practice  good hygiene, wash hands after using the bathroom, before eating 
and after changing a diaper.  
 Avoid consuming contaminated water. Don’t swallow recreational water 
and don’t drink untreated water.  
 If traveling overseas to a developing country be very care of drinking the 
water and of raw food. 
  TREATMENT:- 
  Children and adults who have giardia infection without symptoms 
usually don’t need treatment unless they are likely to spread the parasites. Many 
people who do not have problems often get better on their own in a few weeks. 
   When sings and symptoms are severe or the infection persists, 
doctors usually treat giardiasis with antibiotics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
 In this dissertation work the patients suffering often Masarai Puzhu Noi 
were selected from the post Graduate Kuzhanthai Maruthuvam Inpatient ward of 
Hospital attached to the Govt. Siddha Medical College, Palayamkottai. Those who 
fulfilled the criteria for Masarai Puzhu noi (Giardiasis) according to the 
Pathophysiology of siddha reviews and modern reviews.  
 All the cases were clinically diagnosed by siddha methodology of 
Poriyalarithal (Inspection), Pulanalarithal (Palpation), Vinathal (Interrogation). 
Envagai Thervugal (General Examination), Neerkuri (Urine Analysis), Neikkuri 
and also with male and female children were taken into account for the study. In 
both systems of medicine Siddha and Modern Paediatric professors, Readers, 
Professor of pharmacology, professor of Biochemistry opinion were obtained. A 
detailed proforma was framed and was approved by both the departments of siddha 
and modern paediatrics. 
METHODS:- 
 The patient who fulfilled all the following criteria were selected for this 
 study.  
1. Age  3 to 12 years 
2. These who fulfilled the diagnostic criteria for Masarai Puzhu as per siddha 
and modern system of medicine.  
3. Using this criteria 40 patients were selected for complete study.  
A well framed proforma which contains the proper particular in the siddha 
and modern highlights. In the proforma patients name age, sex information, socio- 
economical status of the parents, educational status of the parents as well as the 
patient’s complaints and duration, present history, previous history, history of pica, 
history of Infections, neo-natal, post-natal history of the patient, muththodam, 
Envagai thervugal, Ezhu udalkaltugal, Neerkuri, Thinai and laboratory histological 
investigations everything were noted.  
 
 
 SIDDHA AND MODERN SYSTEM’S CRITERIA FOR THE DIAGNOSIS 
OF MASARAI PUZHU: 
1. Pain in abdomen 
2. Loss of appetite 
3. Irregular stools 
4. Weight loss 
5. Disturbed sleep and teeth grinding. 
6. Itching around the anus 
7. Vomiting. 
  
 LINE OF TREATMENT IN MASARAI PUZHU 
 When treating for removal of the disease the following principle must be 
noted 
  ‘Neha;ehb Neha; Kjy; ehb mJjzpf;Fk; 
   tha;ehb tha;g;gr; nray;”. 
 And the siddha system is fully based on the herbals 
  ‘NtHg;ghU> jiog;ghU> kpQ;rpdf;fhy; nky;y nky;y 
   gw;g nre;J}uk; ghNu”. 
 Siddha maruthu says first begin treatment with mooligai medicine. If the 
prognosis is poor then slowly use parpam and chendooram.  
1. First bring out the thiridhosa to its normal physiological activities. 
2. Anthelintic are to be administered. 
3. After neutralizing the thiridhoshas appetizer drugs are given to increase the 
appetite. 
4. For improving the blood, Iron preparations are used.  
5. Removal of the causative factors.  
6. Dietic treatment is so equal as medicine. 
Medicine are advised to be in the form of Kudineer, Chooranam, Pills, 
Lehyams, Nei parpam, Chendooranam. The author selected Nayuruvi Nei.  
 In addition Masarai Puzhu Noi symptoms like pain in abdomen, loss of 
appetite, vomiting, teeth grinding, Irregular stools, weight loss, patches on the 
skin, Itching around the anus present.  
TREATMENT:- 
 Treatment is to be based upon accurate recognition of aetiology, diagnosis 
and prognosis of the disease. 
 The proper treatment is based upon proper diagnosis particularly with a 
view to the thiridhosha pathology. 
 Before starting the actual treatment the presence or absence of toxin in the 
body produced due to derangement of thiridhosha’s is noted. 
‘Ngjpahy; thje; jhOk; 
 rj;jpahy; gpj;je; jhOk; 
  mQ;rdj;jhy; fge; jhOk;” 
 In this disease poor hygienie habits, poor sanitation, Improperly cooked 
foods lower the resistance of the individual resulting in upsitting the function of 
Vatha. The deranged vatha causes the dysfunction of kukkianal which permits the 
multiplication of the Intestinal worms in the Aamasayam. 
  
 CLINICAL STUDIES 
 After finishing the toxicity studies 40 cases selected from the OPD and IPD 
of Kuzhanthai Maruthuvam Department, Government Siddha Medical  College, 
Palayamkottai. They were treated with the trail drug Nayuruvi Nei and observed 
for Prognosis clinically. 
STUDY DESIGN & CONDUCT OF THE STUDY. 
 Study Type  : As open clinical study 
 Study Place :Government Siddha Medical College & Hospital,   
                          Palayamkottai. 
 Study Duration : 24 Months  
 Treatment Period : 3 days 
POPULATION AND SAMPLE: 
1. Population consists of pediatric patients attending the Government Siddha 
Medical College & Hospital, Palayamkottai. 
2. The Sample Consists of Patients 3-12 years group fulfilling all the inclusion 
criteria and exclusion criteria. 
STUDY PARTICIPANTS: 
INCLUSION CRITERIA. 
1. Age 3-12 Years 
2. Sex- Both male and female children 
3. Diarrhoea Fever, 
4. Abdominal discomfort 
5. Fatigue 
6. Abdominal Pain 
7. Anorexia, weight loss 
8. Biting the teeth during Night 
9. Nocturnal Perianal pruritis 
10. Dry skin, patches on face. 
 
 
 
 EXCLUSION CRITERIA. 
1. Patients with any other serious systemic illness. 
2. Sometimes a larger bunch of worms may block the intestinal tract and cause 
total constipation, abdominal distension and vomiting. 
3. Long term steroid treatment 
4. Pancreatitis and cholecystitis  
5. Irritable bowel syndrome 
6. Rectal prolapse is the complication of heavy infection of whip worm 
7. Acute stages of hook worm infection causes diarrhea, stool bearing reddish 
or black colour. 
8. Potential impact of hook worm infection in children who can experience 
stunted growth and mental development. In severe type of hook worm 
edema in face and around the eyes. Pot belly is the typical sign in children. 
9. In ascaris worms the most common clinical problem are due to pulmonary 
disease and obstruction of the intestinal or biliary tract. 
WITHDRAWAL CRITERIA. 
 The drug not responding to the condition. 
 Intolerance to the drug and development of adverse reactions during drug 
trial. 
 Patient turned unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness. 
Sample Size :  40 Patients. 
ASSESSMENTS AND INVESTIGATIONS. 
Clinical Assessment. 
 Diarrhoea, Fever, 
 Fatigue 
 Abdominal Pain 
 Anorexia, Weightloss 
 Abdominal discomfort 
 Biting the teeth during night. 
 Nocturnal perianal pruritis. 
  Dry skin, patches on face 
SIDDHA TESTS AND ASSESSMENTS. 
1.Udal Kattukal 
 Saaram 
 Senneer 
 Oonn 
 Kozhuppu 
 Enbu 
 Moolai 
 Sukkilam / Suronitham 
II. Envagai Thervu 
 Naadi 
 Sparisam 
 Naa 
 Niram 
 Mozhi 
 Vizhi 
 Malam 
 Moothiram 
III. Neerkuri 
IV Neikuri 
ROUTINE INVESTIGATIONS. 
1. Blood 
 TC 
 DC 
 ESR 
 HB 
 Absolute Eosinophil count 
 
 
 
 Specific Investigations. 
1. Examination of stools for ova and cyst. 
2. NIH swab-eggs can often be demonstrated in the scraping from perianal 
skin by this method (wherever necessary).  
Data Collection forms 
 Required information will be collected from each patient’s parents/ 
guardian using the following forms. 
Form I : Screening and selection proforma 
Form II : History taking proforma 
From III : Clinical assessment proforma 
Form  IV : Laboratory Investigation proforma 
Form V : Withdrawal form 
Form VI : Patient Information sheet. 
Data Analysis 
 After enrolling the patients in the study a separate file for each patient will 
be maintained and all forms will be kept in the file. Whenever the patients visits 
OPD during the study period necessary entries will be made in the assessment 
forms. 
 The dated entries and adverse events if any will be monitored by the Head 
of the Department. 
OUTCOME TREATMENT 
1. Primary Outcome 
 Primary outcome is mainly assessed by comparing the reduction in clinical 
symptoms and recurrence before and after treatment. 
2. Secondary Outcome 
 Secondary outcome is assessed by comparing the safety parameters before 
and after treatment. 
 
 
 
 
 DRUG REVIEW 
PREPARATION  AND  PROPERTIES  OF  TRAIL  DRUG 
I. ehAUtp nea; (cl;gpuNahfk;) 
E}y; Mjhuhk; 
 Foe;ij kUj;Jtk; (ghy thflk;) gf;f vz; 594 
E}y; Mrphpah; 
 f.r.KUNfr Kjypahh; 
 kU.nghd;.FU rpNuhd;kzp 
ehAUtp nea; 
 “kriuNeha;f; Ff;Nfs; khNd 
  kUTkh tpndd;A of;fpy; 
 Firapdh AUtp Nkdp 
  nfhO Q;rpJ} JisNahh; ehYk;  
 trk;Gld; Rf;F kQ;rs; 
  tifNahh; ghf; fsT $l;bg;  
 girg;gj nkOfha;f; fha;r;rpg;  
  ghpe;Jiu kaiu Neha;Nghk;” 
NrUk; ruf;Ffs; : 
 Fg;igNkdp ,iy  - 6.022 fpuhk; 
 ehAUtp ,iy   - 6.022 fpuhk; 
 nfhSQ;rp ,iy  - 6.022 fpuhk; 
 J}Jtis ,iy  - 6.022 fpuhk; 
 trk;G    - 6.022 fpuhk; 
 Rf;F    - 6.022 fpuhk; 
 kQ;rs;   - 6.022 fpuhk; 
 gR nea;   - 325 kp.yp. 
nra;Kiw : 
 ehAUtp ,iy> Fg;igNkdpapiy> nfhopQ;rpapiy> J}Jtisapiy> 
trk;G> Rf;F> kQ;rs; Mfpa VO nghUl;fisAk; tiff;Fg; ghf;fsT 
tPjnkLj;J jz;zPh;tpl;L miuj;J cof;F (325 kp.yp.) gRnea; Nrh;j;Jf; 
 fha;r;rp nkOF gjj;jpy; tbj;Jf;nfhz;L taJf;Fj; jf;f mstpy; 
nfhLf;f kriug;GO Neha; jPUk;. 
msT  
 5 kp.yp. - 3 Kjy; 5 taJ tiu 
 10 kp.yp. - 5 Kjy; 8 taJ tiu 
 15 kp.yp. - 8 Kjy; 12 taJ tiu 
jPUk; Neha;fs; 
 Fly; fpUkp - kriug;GO 
MAl;fhyk ; 
 6 khjk; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
 PROPERTIES OF TRIAL MEDICINE 
1. ehAUtp 
 Botanical Name : Achyranthes aspera 
 Family  : Amaranthaceae 
 NtW ngah;  : fhQ;rhp> rukQ;rhp> rpW flyhb,   
     nfhl;lhtp> khKdp 
 gad;gLk; cWg;G : ,iy 
 Rit   : ifg;G> Jth;g;G> fhh;g;G 
 nra;if  : Jth;g;gp 
     rpWePh;ngUf;fp 
     clw;Nww;wp 
     Kiwntg;gfw;wp 
 “ kypfhuq; ifg;Gs;s mgkhh;f;fp apd;Ntuhy; trpa Kz;lhk; 
     ,iy%y cjpuke;jk; Ngjpfgk; tpah;Tje;jp apwq;F Nkfk; 
    kiyNaWk; gbGhpA Ks;shprp grpkhw;Wk; tir %yk; 
     gykhjh;f; Fs;s Kf;if ePf;Ftq;fr; rpe;J}uk; gz;ZkhNjh” 
CHEMICAL CONSTITUENTS : 
 Triter penoid saponins. 
 Oleanolic acid 
 Ecdysterone an insect moulting hormone 
 Long Chain alcohol 
 Tritriacontane 
 Achyranthine 
2. Fg;igNkdp  
 Botanical Name  : Acalypha indica 
 Family   : Euphorbiaceae 
 NtW ngah;  : mhpkQ;rhp> G+idtzq;fp> Nkdp 
 gad;gLk; cWg;G : ,iy 
 Rit   : ifg;G 
 
 
  nra;if   : GOf;nfhy;yp 
ngUkyk; Nghf;fp 
rpWePh;g; ngUf;fp  
the;jpAz;lhf;fp 
Nfhioafw;wp 
 “je;j% yg;gpzpjPj; je;jpLGz; rh;ttplk; 
    ce;J Fd;kk; thjk; cjpu% - ye;jpdT 
     #yQ;R thrk; njhlh;gP rq;fgk; Nghk; 
    Qhyq;nfhs; Nkdpaj dhy;” 
CHEMICAL CONSTITUENTS : 
It contains  
 Acalypus 
 Acalyphine 
3. J}Jtis : 
 Botanical Name  : Solanum trilobatum 
 Family  : Solanaceae 
 NtW ngah;  : msh;f;fk;> rpq;fty;yp 
 gad;gLk; cWg;G : ,iy 
 Rit  : rpW ifg;G 
 nra;if  : cukhf;fp 
    Nfhioafw;wp 
    ntg;gKz;lhf;fp 
 
 “ fhJ ke;jk; fhnjOr;rp fhre; jpdT kjk; 
  XJ ke;jk; Kj;Njhlk; cl;#iy -jhJ el;lk; 
    kPJisg; gj;jphpia Nktr;nra; thuha;e;Njhh; 
    J}Jisg; gj;jphpiaj; Ja;j;J ” 
CHEMICAL CONSTITUENTS    
 Leaves contain moisture  
 Proteins, Minerals 
 Crude Fibre and other Carbohydrates 
 4. trk;G 
  Botanical Name  : Acorus calamus 
 Family  : Araceae 
 NtW ngah;  : cf;fpuk;> trk;> ciug;ghd;>  
     gps;is kUe;J 
 gad;gLk; cWg;G : Nth; 
 Rit   : fhh;g;G 
 nra;if  : El;GOf;nfhy;yp 
     njhw;WGOtfw;wp 
     the;jpAz;lhf;fp 
     grpj;jPj;J}z;b 
     mfl;Ltha;tfw;wp 
     ntg;gKz;lhf;fp 
 ‘ghk;ghjp eQ;rw; Gjg;Gz; typtplghfq; Fd;kk; 
   #k;gh hpuj;jgpj;jk; Kf ehw;wk; td; #iyrd;dp 
    tPk;ghk;ig fhrk; gpyPfQ; rpypgjk; tPwpUky; 
   jhk;ghq; fpUkp apitNaF khrpt rk;gpidNa” 
CHEMICAL CONSTITUENTS    : A volatile essential oil acorin,  
       bitter   principle acoretin   
       (Choline), Calamine, Starch 
5.Rf;F 
 Botanical Name  : Zingiber officinale  
 Family  : Zingiberaceae 
 NtW ngah;  : mUf;fd;> mjfk;> cgFy;yk;> tpl%ba  
      mkph;jk;> Rz;b 
 gad;gLk; cWg;G : fpoq;F 
 Rit   : fhh;g;G 
 nra;if  : ntg;gKz;lhf;fp 
     grpj;jPj;J}z;b 
     mfl;Ltha;tfw;wp 
 
  ‘#iyke;jk; neQ;nrhpg;G NjhlNkg; gk;goiy 
   %yk; ,iug;gpUky; %f;FePh; - thyfg 
   Njhlkjp rhue; njhlh;thj Fd;kePh;j; 
   Njhlk; M kk;Nghf;FQ; Rf;F” 
CHEMICAL CONSTITUENTS  
 Polyphenol 
 Vitamin C 
 β Carotene 
 Flavonoids 
 Tannins   
6.kQ;rs; : 
 Botanical Name   : Curcuma longa 
 Family   : Zingiberaceae 
 NtW ngah;  : mhprdk;> fhd;rdp> eprp> gPjk; 
 gad;gLk; cWg;G : fpoq;F 
 Rit   : fhh;g;G 
 nra;if  : mfl;Ltha;tfw;wp 
     ntg;gKz;lhf;fp 
     <uy;Njw;wp 
  “nghd;dpwkhk; Nkdp Gyhdhw;w Kk;NghFk;  
   kd;D GUl trpakhk; - gpd;dpnaOk; 
   the;jpgpj;j Njhlikak; thjk; Nghe; jPgdkhq; 
   $h;e;jkQ;r spd;fpoq;Ff;F.” 
CHEMICAL CONSTITUENTS  
 An essential Oil 
 Resin and alkaloid  
 Curcumine 
 Turmeric Oil 
 Caproic acid 
 
 
 7. nfhSQ;rp 
 Botanical Name   : Tephrosia purpurea 
 Family    : Fabaceae 
 NtW ngah;   : nfhs;Sf;fha;Ntis 
 gad;gLk; cWg;G  : ,iy 
 Rit    : fhh;g;G 
 nra;if   : kyg;GOtfw;wp 
       clYukhf;fp 
       Nfhioafw;wp 
       rPWePh;ngUf;fp 
 
 “thjkpf;f njd;ghh;f;Fk; tha;twl;rp nad;ghh;f;Fk;  
  kPJ je;j %y Neh nad;ghh;f;Fk; - XjKw;w 
  nfhs;Sf;fh jhufgk; Njhw;wpanjd; ghh;f;FnkhU 
  nfhs;Sf;fha; Ntisjidf; $W.” 
 
CHEMICAL CONSTITUENTS : 
 Rotenoids 
 Iso Flavones 
 Flavonones 
 Flavanols 
 Flavones 
 
 
 
 
 
 
 
 
 
 OBSERVATIONS AND RESULTS   
RESULTS WERE OBSERVED WITH RESPECT TO THE FOLLOWING 
CRITERIA. 
 Age Reference 
 Sex Reference 
 Religious Reference  
 Socio economic status in the patient Reference  
 Diet Reference 
 Thinai 
 Paruva kaalam 
 Mode of onset Reference  
 Mukkuttra Verubadukal 
 Ezhu Udarkattugal Reference 
 Envagai Thervugal Reference 
 Neerkuri Neikkuri Reference 
 Aetiology Reference 
 Results after Treatment Reference 
 The observations recorded with the above said criteria were given in 
the tabular form. 
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1. AGE REFERENCE 
2. A 
 
 
 
 
 
 
 
 
 Inference:- 
 The percentage was highest in the age group 6 – 12, the percentage was 
30% percentage between the age 3 – 6 and 9 – 12 was 25% and age 1 – 3 was 
20%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sl. No. Age 
Number of 
cases (Out of 
40) 
Percentage (%) 
1.  1 – 3 8 20 
2.  3 – 6 10 25 
3.  6 – 9 12 30 
4.  9 – 12 10 25 
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2. Female
1. Male
2. SEX REFERENCE 
 
Sl. No. Sex 
Number of 
cases (Out of 
40) 
Percentage 
(%) 
1.  Male Children 16 40 
2.  FemaleChildren 24 60 
 
Inference:- 
 Out of 40 patients 16 were male children and 24 were female children. 
 
 
SEX REFERENCE 
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3.RELIGION REFERENCE 
 
Sl. No. Religion 
Number of 
cases (Out of 
40) 
Percentage (%) 
1.  Hindu 29 72.5 
2.  Christian 3 7.5 
3.  Muslim 8 20 
 
Inference:- 
 In 40 cases 72.5% of cases were Hindu 7.5% were Christian, 20% were 
Muslim 
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4. SOCIO ECONOMIC STATUS 
 
Sl. No. 
Socio – economic 
status 
Number of 
cases (Out of 
40) 
Percentage (%) 
1.  Lower Income Groups 22 55 
2.  
Middle Income 
Groups 
11 27.5 
3.  High Income Groups 7 17.5 
 
Inference:- 
 Out of 40 patients 55% of cases were lower, 27.5% of cases were middle 
and 17.5% of cases were rich.  
 
SOCIO ECONOMIC STATUS 
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5. DIET REFERENCE 
 
Sl. No. Diet Habit 
Number of cases 
(Out of 40) 
Percentage (%) 
1.  Vegetarian 5 12.5 
2.  Mixed Diet 35 87.5 
 
Inference:- 
 Out of 40 patients 12.5% of cases were vegetarian diet and 87.5% of cases 
were mixed diet. 
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6. THINAI 
Sl. No. Thinai 
Number of 
cases (Out of 
40) 
Percentage (%) 
1.  Kurinji - - 
2.  Mullai - - 
3.  Marutham 38 95 
4.  Neithal 2 5 
5.  Paalai - - 
 
Inference:- 
 Out of 40 patients 95% of cases belongs to Marutham and 5% of cases 
belongs to Neithal. 
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7. PARUVA KAALAM 
Sl. No. Paruvakalam 
Number of cases  
(Out of 40) 
Percentage 
(%) 
1.  
Kaar kaalam  
(Aavani – Purataasi) - - 
2.  
Koothir kaalam 
(Ayppasi - kaarthigai) - - 
3.  
Munpani kaalam 
(Maarkazhi - Thai) 
22 55 
4.  
Pinpani kaalam 
(Maasi - panguni) 
13 32.5 
5.  
Ilavenil kaalam 
(Chithirai - vaikasi) 5 12.5 
6.  
Muthuvenil kaalam 
(Aani - Aadi) 
- - 
 
Inference:- 
 According to Paruvakaalam high incidence of 55% of cases in Munpani 
kaalam, 32.5% of cases in Pinpani kaalam and 12.5% of cases in Ilavenil kaalam. 
PARUVA KAALAM 
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8. MODE OF ONSET 
Sl.No. Mode of Onset Number of Cases (out of 40) Percentage 
1 Acute 32 80 
2 Chronic 8 20 
 
 
Inference 
 Out of 40 Cases 80% of Cases had acute onset of symptoms and 20% of 
cases had chronic onset of symptoms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
9. CLINICAL FEATURES DURING ADMISSION 
Sl.No Clinical Features Number of Cases 
(Out of 40) 
Percentage 
% 
1 Pain in abdomen 32 80 
2 Itching around the anus 38 95 
3 Irregular stools 28 70 
4 Loss of  appetite 39 97.5 
5 Loss of body weight 14 35 
6 Worms in feaces 34 85 
7 Teeth grinding 36 90 
8 White Patches on skin 34 85 
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 Inference: 
 Pain in abdomen was present in 32 cases (80%) 
 Itching around the anus was present in 38 cases (95%) 
 Irregular stools was present in 28 cases (70%) 
 Loss of appetite was present in 39 cases (97.5%) 
 Loss of body weight was present in 14 cases (35%) 
 Worms in faeces was present in 34 cases (85%) 
 Teeth grinding was present in 36 cases (90%) 
 White Patches on skin was present in 34 cases (85%) 
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10. THIRIDHOSHA REFERENCE 
RESULTS SHOWING THE DERANGEMENT OF VATHAM 
Sl.No Clinical Features Number of Cases (Out 
of 40) 
Percentage 
% 
1 Pranan - - 
2 Abanan 31 77.5 
3. Viyanan 34 85 
4 Uthanan 20 50 
5 Samanan 36 90 
6 Nagan - - 
7 Koorman - - 
8 Kirukaram 31 77.5 
9. Devathathan - - 
10. Thananjeyan - - 
 
 
 
 
 
 
   
 
  
 
 
 
 
 
 
 
 
 Inference 
 Derangement of Abanan was observed in 31 cases (77.5%) 
 Derangement  of Viyanan was observed in 34 cases  (85%) 
 Derangement of Uthanan was observed in 20 cases (50%) 
 Derangement of Samanan was observed in 36 Cases (90%) 
 Derangement of Kirukaran was observed in 31 Cases (77.5%) 
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RESULTS SHOWING THE DERANGEMENT OF PITHAM 
 
Sl.No Classification of Pitham No. Of Cases (Out 
of 40) 
Percentage 
% 
1 Anila Pitham 33 82.5 
2 Ranjakam 31 77.5 
3 Sathakam 8 20 
4 Aalosakam - - 
5 Prasagam 33 82.5 
 
 
 
 
 
 
 
 
 
 
 
 
Inference 
 Derangement of Anila Pitham was observed in 33 cases  (82.5%) 
 Derangement of Ranjakam was observed in 31 cases (77.5%) 
 Derangement of sathakam was observed in 8 cases (20%) 
 Derangement of Prasagam was observed in 33 cases (82.5%) 
 
 
 
 
 
RESULTS SHOWING THE DERANGEMENT OF KABAM 
Sl.No Classification of Kabam No. Of 
Cases (Out 
of 40) 
Percentage 
% 
1 Avalambagam - - 
2 Kilethagam 34 85 
3 Pothagam - - 
4 Tharpagam - - 
5 Santhigam - - 
  
 
 
Inference 
 Derangement of Kilethagam was observed in 34 cases (85%) 
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11. EZHU UDARKATTUGAL 
Sl.No Udarkattugal No. Of 
Cases (Out 
of 40) 
Percentage 
% 
1 Saaram 34 85 
2 Senneer 34 85 
3 Oon - - 
4 Kozhuppu - - 
5 Enbu - - 
6 Moolai - - 
7 Sukkilam/ Suronitham - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference 
 Saaram was affected in 34 cases (85%) 
 Senneer was affected in 34 cases (85%) 
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12. ENVAGAI THERVUGAL REFERENCE 
Sl.No Envagai Thervugal No. Of Cases (Out 
of 40) 
Percentage 
1 Naa 27 67.5 
2 Niram 34 85 
3 Mozhi - - 
4 Vizhi - - 
5. Sparisam - - 
6. Malam 34 85 
7 Moothiram - - 
8 Naadi (Vatha Kalappu) 31 77.5 
 
ENVAGAI THERVUGAL REFERENCE 
 
 
 
 
 
 
 
 
 
 
Inference: 
 Naa was affected in 27 cases  (67.5%) 
 Niram was affected in 34 cases (25%) 
 Malam was affected in 34 cases  (85%) 
 Naadi (Vathakalappu) was observed in 31 cases (77.5%) 
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13. NEERKURI, NEIKURI REFERENCE 
Sl.No Neerkuri, Neikuri No. Of Cases 
(Out of 40) 
Percentage 
1 Neerkuri Vaikkol Niram 40 100 
2 Neikuri Vadham 18 45 
3 Neikuri Pitham 22 55 
4 Neikuri Kabam - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference 
 In all the 40 cases the Neerkuri was vaikkol Niram (100%). In 18 cases the 
Neikuri was Vatha Neer (45%). In 22 cases the Neikuri was pitha Neer (55%) 
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14. AETIOLOGY REFERENCE 
Sl.No AETIOLOGY 
REFERENCE 
No. Of Cases 
(Out of 40) 
Percentage 
1 Picca 7 17.5 
2 Poor Dietary Habits 34 85 
3 Drinking unsterilized water 
drawn from polluted sources 
33 82.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference 
 Picca was the Aetiological Factor 7 Cases (17.5%) 
 Poor dietary habits was the Aetiological factor in 34 cases (85%) 
 Drinking unsterlised water drawn from polluted sources was the aetiological 
factor in 33 cases 82.5% 
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15. RESULTS AFTER TREATEMENT 
Sl.No Results No. Of 
Cases (Out 
of 40) 
Percentage 
1 Good Relief 35 87.5 
2 Moderate Relief 5 12.5 
3. Mild Relief - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference 
 Good Relief was observed in 35 patients (87.5%) 
 Moderate Relief was observed in 5 patients (12.5%) 
 
 
 
 
 
 
  
Out Patients Record 
S. 
No O.P. No Name Age Sex 
No.of 
days 
treated 
Remarks 
1. 109354 Esakkiraj Tharan 9 Mc 3 Good 
2. 109296 Muthu Gomathi 9 Fc 3 Good 
3. 109774 Thahira 3 ½ Fc 3 Good 
4. 112649 Siva Ganesh 7 Mc 3 Moderate 
5. 7476 Venkatesh 4 ½ Mc 3 Good 
6. 7764 Hiba 10 Fc 3 Good 
7. 8096 Sriram 8 Mc 3 Good 
8. 9193 Abdul Raheem 3 Mc 3 Good 
9. 9582 Ramesh 6 Fc 3 Good 
10. 9876 Indu 10 Fc 3 Good 
11. 10358 Samreena 9 Fc 3 Good 
12. 10374 Babu 5 Mc 3 Good 
13. 1148 Anuska 9 Fc 3 Good 
14. 12194 Subiksha 3 Fc 3 Good 
15. 12451 Venkat 12 Mc 3 Good 
16. 12470 Manisankar 12 Mc 3 Good 
17. 13387 Nazrin 3 Fc 3 Good 
18. 13460 Afrin 5 Fc 3 Good 
19. 14761 Rani 3 Fc 3 Good 
20. 15327 Tharani 5 Mc 3 Moderate 
 
 
 
 
 
 INVESTIGATIONS OF 20 IN PATIENTS OF MASARAI PUZHU 
Sl. 
No 
IP 
No 
Name of the 
patient 
Hematological Investigations 
Before Treatment After Treatment 
TC 
/cumm 
DC% ESR mm 
Hb% TC/ cumm 
DC % ESR mm 
Hb% P L E 1/2 hr 1 hr P L E 1/2hr 1 hr 
1 157 Katheeja 8FC 8,500 44 51 5 6 12 11.3 8,300 46 53 1 5 11 11.4 
2 233 Sreemathy 11FC 8,800 66 30 4 7 13 12.9 8,800 68 30 2 6 12 12.9 
3 260 Kamatchi 7FC 8,200 44 39 17 4 8 11.5 8,100 54 44 2 3 7 11.6 
4 365 Mari sankar 10 MC 8,600 58 40 2 5 9 13 8,600 58 40 2 4 8 13 
5 424 Renukha 3FC 7,500 50 48 2 6 11 12 7,400 50 48 2 5 10 12 
6 436 Archana 5Fc 8,000 60 36 4 7 13 10.5 8,000 64 36 - 6 12 10.5 
7 528 Gipson 31/2Mc 7,600 66 32 2 8 15 11.6 7,500 66 33 1 7 14 11.8 
8 643 Narisa 10Fc 7,300 64 32 4 9 18 12.3 7,200 66 32 2 8 16 12.5 
9 657 Salman 11Mc 7,200 55 41 4 6 12 10.4 7,100 57 41 2 5 10 10.4 
10 659 Haribabu 9mc 8,600 58 38 4 5 11 11.6 8,500 60 38 2 5 10 11.6 
11 741 Sandhana Priya 3Fc 9,000 50 48 2 6 13 10.9 8,800 51 49 - 6 12 11 
12 765 Vishalini 12Fc 9,200 44 51 5 8 16 10.5 9,000 46 53 1 7 14 11 
13 833 Sanjay 9Mc 8,600 60 39 1 8 17 11 8,400 60 39 1 8 16 11 
14 955 Pavithra 3Fc 8,200 70 26 4 9 18 10 8,200 72 26 2 6 12 10.2 
15 1011 Levisha Lourd 4Fc 8,400 68 30 2 6 12 9.8 8,200 70 30 - 5 10 9.8 
16 1053 Kanagalakshmi 8Fc 8,800 72 25 3 4 8 11.4 8,800 73 25 2 3 6 11.6 
17 1078 Keerthana 8Fc 7,800 50 48 2 5 9 12.2 7,600 50 50 - 4 8 12.2 
18 1131 Jejas 3 Mc 7,000 64 32 4 3 7 11.3 8,800 66 32 2 3 6 11.3 
19 1147 Ramesh 10Mc 8,500 65 33 2 6 9 10.6 8,300 65 34 1 4 8 10.6 
20 1146 Nisha 3Fc 7,800 55 40 5 5 10 10.2 7,600 57 41 2 4 8 10.2 
 INVESTIGATION OF 20 IN PATIENTS OF MASARAI PUZHU 
Sl.No IP No Name of the patient 
Urine Analysis Motion Analysis 
Before Treatment After Treatement  Before Treatment After Treatment 
Alb Sug Dep Alb Sug Dep Ova Cyst Occult  blood Ova Cyst 
Occult  
blood 
1 157 Katheeja 8FC Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
2 233 Sreemathy 11FC Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
3 260 Kamatchi 7FC Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
4 365 Mari sankar 10 MC Nil Nil NAD Nil Nil NAD G.O Nil Nil G.O Nil Nil 
5 424 Renukha 3FC Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
6 436 Archana 5Fc Nil Nil 1-2 Puscells Nil Nil NAD G.O Nil Nil Nil Nil Nil 
7 528 Gipson 31/2Mc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
8 643 Narisa 10Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
9 657 Salman 11Mc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
10 659 Haribabu 9mc Nil Nil 1-2 Puscells Nil Nil NAD G.O Nil Nil G.O Nil Nil 
11 741 Sandhana Priya 3Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
12 765 Vishalini 12Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
13 833 Sanjay 9Mc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
14 955 Pavithra 3Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
15 1011 Levisha Lourd 4Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
16 1053 Kanagalakshmi 8Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
17 1078 Keerthana 8Fc 61 Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
18 1131 Tejas 3 Mc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
19 1147 Ramesh 10Mc Nil Nil NAD Nil Nil NAD G.O Nil Nil Nil Nil Nil 
20 1146 Nisha 3Fc Nil Nil NAD Nil Nil NAD G.O Nil Nil G.O Nil Nil 
 In Patients Record 
S. 
No 
IP 
No Name Clinical Features 
Duration of 
Illness 
(Month) 
D.O. A D.O.D 
No of 
Days 
Treated 
Prognosis 
1 157 Katheeja 8FC 
Pain in abdomen, Itching around 
anus, constipation 1 24.01.16 28.01.16 5 Good 
2 233 Sreemathy 11FC 
Pain in abdomen, Los of appetite, 
Itching around anus 
1 30.01.16 02.02.16 4 Good 
3 260 Kamatchi 7FC Weight loss, loss of appetite, 
worms in faeces 
2 01.02.16 05.02.16 4 Moderate 
4 
365 Mari sankar 10 MC 
Pain in abdomen, Itching around 
anus, white patches on face 
1 12.02.16 16.02.16 4 Good 
5 424 Renukha 3FC 
Itching around anus, Teeth 
grinding, patches on face 
1 17.02.16 20.02.16 4 Good 
6 436 Archana 5Fc Pain in abdomen, loss of appetite, 
worm in faeces 
1 18.02.16 21.02.16 4 Good 
7 528 Gipson 31/2Mc 
Loss of appetite, weight loss, 
Itching around anus. 
2 27.02.16 01.03.16 4 Good 
8 643 Narisa 10Fc 
Pain in abdomen, Itching around 
the anus, worm in faeces. 
1 09.03.16 12.03.16 4 Good 
9 657 Salman 11Mc 
Pain in abdomen, loss of appetite, 
Itching around anus. 2 10.03.16 14.03.16 4 
Good 
 
10 659 Haribabu 9mc 
Weight loss, Teeth grinding, 
Patches on face 
2 10.03.16 14.03.16 4 Moderate 
 11 741 Sandhana Priya 3Fc 
Itching around anus, Constipation, 
weight loss. 
1 18.03.16 21.03.16 4 Good 
12 765 Vishalini 12Fc 
Pain in abdomen, loss of appetite, 
Worms in faces 
1 21.03.16 24.03.16 3 Good 
13 833 Sanjay 9Mc 
Weight loss, Teeth grinding, 
Patches on face 1 28.03.16 31.03.16 4 Good 
14 955 Pavithra 3Fc 
Pain in abdomen, Itching around 
the anus, constipation 
2 07.04.16 09.04.16 3 Good 
15 1011 Levisha Lourd 4Fc 
Itching around the anus, teeth 
grinding, white patches on face. 
3 14.04.16 18.04.16 4 Moderate 
16 1053 Kanagalakshmi 8Fc 
Weight loss, teeth grinding, 
Patches on face 2 19.04.16 22.04.16 4 Good 
17 1078 Keerthana 8Fc 
Weight loss, loss of appetite, 
worm in faeces 
2 21.04.16 24.04.16 4 Good 
18 1131 Jejas 3 Mc 
Pain in abdomen, Itching around 
anus, constipation 
1 27.04.16 30.04.16 4 Good 
19 1147 Ramesh 10Mc 
Itching around anus, Teeth 
grinding, patches on face 3 29.04.16 02.05.16 4 Good 
20 1146 Nisha 3Fc 
Loss of appetite, weight loss, 
Itching around anus 
1 29.04.16 02.05.16 4 Moderate 
 
 
 
 DISCUSSION 
Helminthic infestations contribute significantly to global burden of disease in 
children especially in the tropical and subtropical regions. 
Most helminthic are potentially pathogens to human beings if these are present in 
sufficient number. They may cause disease in children by the following 
mechanisms.  
1. By depriving the nutrients of the host. 
2. By sucking the blood from host 
3. By interfering with the body function mechanically. 
Masarai Puzhu is considered as the commonest infection affecting the children 
Regarding Masarai Puzhu 16 were male children (40%) 24 were female children 
(60%) 
Regarding Masarai Puzhu 8 patients were between the age group 1-3 (20%) 10 
patients between the age group 3-6 (25%) 12 patients were between the age group 6-
9 (30%) 10 patients were between the age group 9-12(25%) 
Regarding Masarai Puzhu 29 patients were Hindus. 3 Patients were Christians and 8 
patients were muslims. 
Regarding Masarai Puzhu 22 patients were from poor Socio-economic status (55%) 
11 were from middle socio - economic status (27.5%) 7 were from rich economic 
status (17.5%) 
Regarding Masarai Puzhu 5 patients were vegetarians (12.5%), 35 patients were 
Non - vegetarians (87.5%) 
Regarding Masarai Puzhu 38 patients were from Marutham (95%) 2 patients were 
from Neithal (5%) 
Regarding Masarai Puzhu 22 patients admitted during munpanikaalam (55%) 13 
patients were admitted during pinpanikaalam (32.5%) 5 patients were admitted 
during Ilavenil Kaalam (12.5%). 
Regarding Masarai Puzhu 32 patients had acute onset (80% ) 8  patients had chronic 
onset (20%). 
 Regarding Masarai Puzhu Among 40 patients. 
 Pain in abdomen was present in 32 cases (80%) 
 Itching around the anus was present in 38 cases (95%) 
 Irregular stools was present in 28 cases (70%) 
 Loss of appetite was present in 39 cases (97.5%) 
 Loss of body weight was present 14 cases (35%) 
 Worms in faeces was present in 34 cases (85%) 
 Teeth grinding was present in 36 cases (90%) 
 White patches on skin was present in 34 cases  (85%) 
Regarding Masarai Puzhu Among 40 patients  
 Derangement of Abanan was observed in 31 cases (77.5%) 
 Derangement of Viyanan was observed in 34 cases (85%) 
 Derangement of Uthanan was observed in 20 cases (50%) 
 Derangement of Samanan was observed in 36 cases (90%) 
 Derangement of Kirukaran was observed in 31 cases (77.5%) 
Regarding Masarai Puzhu among 40 patients 
 Derangement of Anilapitham was observed in 33 cases (82.5%) 
 Derangement of Ranjakam was observed in 31 cases (77.5%) 
 Derangement of Sathakam was observed in 8 cases (202%) 
 Derangement of Prasagam was observed in 33 cases (82.5%) 
Regarding Masarai Puzhu among 40 patients 
 Derangement of Kilethagam was observed in 34 cases (85%) 
 Regarding Giardiasis among 40 patients. 
 Saaram was affected in 34 cases (85%) 
 Senneer was affected in 34 cases (85%) 
Regarding Masarai Puzhu among 40 patients 
 Naa was affected in 27 cases (67.5%) 
 Niram was affected in 34 cases 85% 
 Malam was affected in 34 cases 85% 
  Naadi (Vatha Kalappu) was seen in 31 cases (77.5%) 
 The Colour of the Urine in all cases was Vaikkol Niram 
 In all cases the Urine was Vatha and Pitha neer. 
Regarding Masarai Puzhu among 40 patients 
 Picca was the aetiological factor in 7 cases (17.5%) 
 Poor dietary was the aetiological factor in 34 cases (85%) 
 Drinking unsterilized water drawn from polluted sources was the aetiological 
factor in 33 cases (82.5%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 RESULTS AND OBSERVATION 
Reference of Results 
 In case of Masarai Puzhu good response of this trial drug was observed in 35 
cases (87.5) moderate response was observed in 5 patients (12.5%) 
 This study reveals that with the treatment of trial drug maximum number of cases 
showed good results. 
 The trial Medicine for the treatment of “KUDAL KIRUMI - MASARAI PUZHU” 
was ‘NAYURUVI NEI’ Out of 40 patients treated with NAYURUVI NEI good results 
was found in 87.5% of cases moderate results was found in 12.5% of cases based on the 
evidence of motion examination at the time of admission and discharge. The 
“NAYURUVI NEI” has got more effective anthelmintic action on MASARAI PUZHU    
 Pharmacological studies were carried out in the department of pharmacology KM 
college of pharmacy. The internal medicine. “NAYURUVI NEI’” had very good 
anthelmintic and very good anti spasmodic action. 
 Bio-Chemical analysis was carried out in the Department of Biochemistry 
Governemnt Siddha Medical College, Palayamkottai. 
 Anti-microbial actions were carried out in Malar Microbiological Laboratory, 
Tirunelveli. 
TREATMENT: 
 Out of 40 patients treated with “NAYURUVI NEI” 87.5% of cases has cured and 
12.75 had moderate relief. Based on the laboratory investigation at the time of admission 
and discharge the “NAYARUVI NEI” has got more effective anthelmintic action for 
MASARAI PUZHU. 
 
 
 
 
 
 
 SUMMARY 
 Infection is most prevalent in tropical and subtropical climates due to lack of 
sanitary facilities or the use of human faeces as fertilizer (night soil). Infection may also 
acquired through ingestion of contaminated low worm load. Clinical manifestations occur 
due to intestinal complications. 
 40 patients from both sexes of different age group were selected and a careful 
detailed history was elicited and diagnosis was made on both the Siddha and Modern 
Pathology. Among 40 patients 16 were male children and 24 were female children. 
 The patients were treated with “NAYURUVI NEI” internally in the inpatient ward 
of postgraduate Kuzhanthai Maruthuvam department. 
 Modern Investigations is also be done. Some of the patients varied in sex and in all 
other aspects such as socio economic status. I took a statistics with the aid of details 
mentioned in the case sheet. 
 Pharmacological studies were carried out in the department of pharmacology, KM 
College of Pharmacy. The internal medicine “Nayuruvi Nei” had very good anthelmintic. 
action and very good anti-spasmodic action.  
 Microbiological actions of NAYURUVI NEI shows sensitive against E.coli and 
klebseilla 
 The detailed clinical analysis of the trial drug is done in the Bio-Chemical 
laboratory in Government Siddha Medical College, Palayamkottai. 
 During the course of treatment no signs of complications were reported and 
recorded. 
On the basis of clinical results achieved with the evidence of faeces examination at the 
time of admission and discharge. The “NAYURUVI NEI” was proved to be more 
effective in anthelmintic action for Giardiasis where more than 87.5% of the cases were 
completely relieved. 12.5% of cases were relieved satisfactory. 
 
 
 
 CONCLUSION 
 In this clinical study results were found to be satisfactory. Almost the clinical 
features of Masarai Puzhu correlates with Giardiasis. 
 The results revealed that the predisposing factor for Masarai Puzhu were 
contaminated food, unhygienic habits, lack of environmental sanitation and poor socio-
economic condition of the affected person. 
 The trial medicine Nayuruvi Nei is effective and given good results in the present 
study. Research findings showed that 87.5% of cases have been completely cured and 
12.5% of cases showed moderate response. 
 Microbiological actions of NAYURUVI NEI shows sensitive against E.coli and 
klebseilla 
 The preparation and administration of the trial drug was very simple, economically 
viable, easily available. Clinically the drugs are free from adverse effects. 
 So it is concluded that the drug “NAYURUVI NEI” is effective in the treatment of 
“KUDAL KIRUMI - MASARAI PUZHU” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
  
 
 
 
 
 
  
 
 
 
 
 ANNEXURE II 
BIO – CHEMICAL ANALYSIS (WITHOUT NEI) 
BIO – CHEMICAL ANALYSIS OF NAYURUVI NEI PREPARATION OF THE 
EXTRACT 
             5gms of the drug was weighed accurately and placed in 250ml clean beaker Then 
50ml of distilled water is added and dissolved well. Then it is boiled well for about 10 
minutes. It is cooled and filtered in a 100ml volumetric flask and then it is makeup to 
100ml with distilled water.  This fluid is taken for analysis. 
QUALITATIVE ANALYSIS  
S.NO 
 
             EXPERIMENT OBSERVATION  INFERENCE 
1 TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube. To this add 
2ml of 4% Ammonium oxalate 
solution. 
A white precipitate 
is formed 
Indicates the 
presence  
of calcium 
2 TEST FOR SULPHATE: 
2ml of the extract is added to 5% 
barium chloride solution. 
A  white 
precipitate 
Is formed 
Indicates the 
presence  
of sulphate 
3 TEST FOR CHLORIDE: 
The extract is added with silver nitrate 
solution 
A white precipitate  
Is formed 
Indicates the 
presence  
 of chloride 
4 TEST FOR CARBONATE: 
The substance is treated with 
concentrated Hcl 
No brisk 
Effervessence is 
formed 
Absence of 
chloride 
5 TEST FOR STARCH: 
The extract is added with weak iodine 
solution. 
Blue colour is 
formed 
Indicates the 
presence 
of starch 
 6 TEST FOR IRON FERRIC: 
The extract is acidified with Glacial 
acetic acid and potassium ferro 
cyanide. 
No blue colour is 
formed 
Abseence  of 
ferric iron 
7 TEST FOR IRON FERROUS: 
The extract is treated with 
concentrated Nitric acid and 
Ammonium thio cyanate solution. 
Blood red colour is 
formed 
Indicates the 
presence 
of ferrous iron 
8 TEST FOR PHOSPHATE: 
The extract is treated with Ammonium 
Molybdate and concentrated nitric 
acid. 
No yellow 
precipitate is 
formed 
 Absence of 
phosphate 
9 TEST FOR ALBUMIN: 
The extract is treated with Esbach’s 
Reagent. 
 No yellow 
precipitate is 
formed 
 Absence of 
Albumin 
10 TEST FOR TANNIC ACID: 
The extract is treated with ferric 
chloride. 
No colour change  Indicates the  
absence of 
Tannic acid 
  
 11 TEST FOR UNSATURATION: 
Potassium permanganate solution 
is added to the extract. 
It gets 
decolourised 
Indicates the 
presence of 
unsaturated 
compound 
12 TEST FOR  THE REDUCING 
SUGAR: 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and 
added 8-10 drops of the extract 
and again boil it for 2 mts. 
colour change 
occurs 
Presence of 
reducing 
sugar 
13 TEST FOR AMINO ACID: 
One or two drops of the extract is 
placed on a filter paper and dried 
it well. After drying, 1% 
Ninnydrin is sprayed over the 
same and dried it well. 
Violet colour is 
formed 
 Indicates the 
presence of 
Amino acid 
14 TEST FOR ZINC: 
The extract is treated with 
potassium ferrocyanide. 
No white 
precipitate is 
formed 
Absence of 
Zinc 
The trial drug “Nayuruvi Nei” 
 Calcium 
 Suphate 
 Choride 
 Starch 
 Ferrous iron 
 Reducing Sugar 
 Unsaturated compound 
 Amino acid 
  
EVALUATION OF ANTHELMINTIC ACTIVITY OF SIDDHA FORMULATION 
NAYURUVI NEI 
INTRODUCTION 
 Helminthiasis is among the most important animal diseases inflicting heavy 
production losses. The disease is highly prevalent particularly in third world countries 
due to poor management Helminthiasis practices(1) 4. A number of medicinal plants 
have been used to treat parasitic infections in man and animals.(2,3,4,5)5,6,7, 8 The 
plants are known to provide a rich source of botanical anthelmintics.(6,7)9,10 The 
anthelmintic assay was carried as per the method of Ajaiyeoba et al.(8)11 with minor 
modifications. The assay was performed on adult Indian earthworm, Pheretima posthuma 
and Tubifex tubifex due to its anatomical and physiological resemblance with the 
intestinal roundworm parasite of human beings.(9,10,11,12) 12,13,14,15. Because of easy 
availability, earthworms have been used widely for the initial evaluation of anthelmintic 
compounds in vitro (13-17)16,17,18,19,20. The objective of the present research has to 
prove traditional anthelmintic use of the siddha formulation nayuruvi nei. 
MATERIALS AND METHODS 
Worms: 
Indian earthworm Pheretima posthuma(Annelida) were collected from the water 
logged areas of soil in madurai. Tubifex tubifex (Annelida) were collected from 
Aquarium of the local market. The average size of Pheretima posthuma and Tubifex 
tubifex were 6-8 cm and 1-1.5 cm respectively.They were washed with water to remove 
dirt. 
Chemicals: 
_ Piperazine Citrate (Glaxo) 
_ Double distilled water 
Procedure: 
The anthelmintic assay was carried as per the method of Ajayieoba E. O. et al. with 
minor 
 Modifications(2)5. The experiments were done on adult Indian earthworm Pheretima 
posthuma 
and the aquarium worm,Tubifex tubifex,because they belong to same group of 
Annelida (Mueller, 1774). 20 ml formulations containing three different concentrations, 
Nayuruvi nei (25, 50 and 100 mg/ml in double distilled water) were prepared and 
taken in different petridishes and six earthworms (same type) were placed in the 
solutions respectively. Similarly lump of Tubifex worms were placed in the test 
solutions. All the test solution and standard drug solution were prepared freshly before 
starting the experiments. Time for paralysis was noted when no movement of any sort 
could be observed except the worms were shaken vigorously. Time for death of worms 
were recorded after ascertaining that the worms neither moved when shaken vigorously 
nor when dipped in warm water at 50°C. Piperazine citrate (10 mg/ml) was used as 
reference standard while distilled water as the control.(18)21 Three sets of experiments 
were done statistical significance. 
RESULTS 
TABLE NO .1. 
Anthelmintic activity of NAYURUVI NEI (Mean±SD) 
GROUPS CONC 
MG/ML 
Pheretima 
Posthuma 
 
Paralyzing 
Time 
Pheretima 
Posthuma 
Death Time 
Tubifex 
tubifex 
 
Paralyzing 
Time 
Tubifex 
tubifex 
Death Time 
NORMAL 
CONTROL 
- - - - - 
NAYURUVI 
NEI 
25 62.86±0.666 83.76±0.666 63.00±2.082 75.39±1.453 
NAYURUVI 
NEI 
50 35.33±0.881 63.33±0.881 32.33±0.666 36.33±0.881 
NAYURUVI 
NEI 
100 19.33±0.881 40.00±0.577 14.66±0.881 20.66±1.333 
PIPERAZINE 
CITRATE 
10 25±1.155 64±0.881 22.66±1.764 45.33±1.202 
 DISCUSSION 
From the above study it was seen that the nayuruvi nei showed dose dependent   anti 
helmintic activity as compared to a standard drug piperazine citrate. The mean  
paralyzing time of Pheretima posthuma with the dose of 25, 50 and 100 mg/ml were 
found to be 62.86, 35.33 and 19.33 minutes respectively.In the meantime piperazine 
citrate  at a dose of 10 mg/ml cause paralysis in the above helminth in 25 minutes.The 
mean death  time of Pheretima posthuma with the dose of 25, 50 and 100 mg/ml were 
found to be 83.76, 63.33 and 40.00 minutes respectively. In the meantime piperazine 
citrate at a dose of 10 mg/ml cause paralysis in the above helminth in 64 minutes .The 
mean paralyzing time of Tubifex tubifex with the dose of 25, 50 and 100 mg/ml were 
found to be 63.00, 32.33 and 14.66 minutes respectively.In the meantime piperazine 
citrate at a dose of 10 mg/ml cause paralysis in the above helminth in 22.66 minutes.The 
mean death time of Tubifex tubifex with the dose of 25, 50 and 100 mg/ml were found to 
be 75.39,36.33 and 20.66 minutes respectively. In the meantime piperazine citrate at a 
dose of 10 mg/ml cause death in the above helminth in 45.33 minutes. 
CONCLUSION 
In this investigation the nayuruvi nei were used to evaluate anthelmintic activity by using 
the above models. The present study ofnayuruvi nei  proves its Anthelmintic 
property.Current study gives the evidence that it may be a fruitful medicine of 
tomorrow.Further research is going on to isolate the phytoconstituent for anthelmintic 
activity. 
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 SMOOTH  MUSCLE RELAXANT ACTIVITY OF SIDDHA 
PREPARATION NAYURUVI NEI IN SWISS ALBINO MICE 
Introduction 
 The present study was carried out see the effect of siddha preparation nayuruvi nei 
on muscle relaxant activity. 
Material and methods 
Animals used 
 Swiss albino mice of either sex with weighing 18-26 g were used. The animals 
were maintained on the suitable nutritional and environmental condition throughout the 
experiment. The animals were housed in polypropylene cages with paddy house bedding 
under standard laboratory condition for an acclimatization periods of 7 days prior to 
performing the experiment. The animals were fed with commercially available rat 
pelleted diet. Water was allowed ad libitum under strict hygienic conditions. 
Rotarod 
 The rotarod apparatus consists of a metal rod (3 cm diameter) coated with rubber 
attached to a motor with the speed adjusted to 2 rotations per minute. The rod is 75 cm in 
length and is divided into 6 sections by metallic discs, allowing the simultaneous testing 
of 6 mice. The rod is in a height of about 50 cm above the tabletop in order to discourage 
the animals from jumping off the roller. Cages below the section serve to restrict the 
movements of the animals when they fall from the roller. Swiss albino mice underwent a 
pretest on the apparatus. Only those animals, which had demonstrated their ability to 
remain on the revolving rod (20 rpm) for 5 min, were used for the test.(1,2,3). Swiss 
albino mice were divided into four groups consisting of six animals each. Group I served 
as control which received saline solution , animals of group II received standard drug 
Diazepam at a dose of (5mg/kg, i.p.) while Group III & IV received the siddha 
preparation nayuruvi nei at a dose of 15ml/kg and 30 ml/kg, p.o. The animals were placed 
on the rotating rod and fall off time i.e, when the animal falls from the rotating rod, was 
recorded, which was taken as grip strength. 
 
 Traction test(4) 
 Placing the forepaws of the mice in a small twisted wire rigidly supported above 
the bench top did the screening of animal. Normally the mice grasp the wire with the 
forepaws, and place at least one hind foot on the wire without 5 second when allowed to 
hang free.The test was conducted on four groups of animals (n=8) that were previously 
screened, 30 min after the administration of siddha preparation nayuruvi nei, diazepam (5 
mg/kg) and saline solution as a vehicle control. Inability to put up at least one hind foot 
on the wire is counted as negative value. 
Statistical analysis 
 The data obtained in present investigation was subjected to statistical analysis. All 
results aremexpressed as Mean ± SEM (standard error of mean); Six animals in each 
group. All statistical  comparisons were made by Newmann keuls multiple range tests 
after conducting one -way ANOVA. 
Results and Conclusion 
Rotorod test 
 In this test, siddha preparation nayuruvi nei (15 and 30 ml/kg) both significantly 
reduced the time spent by the animals on revolving rod when compared to Control 
(P<0.05). The standard drug (diazepam) also showed significant effect when compared to 
control (P<0.01). (Table I). 
Traction test 
 In traction test, siddha preparation nayuruvi nei (15 and 30 ml/kg) both 
significantly decreases the muscle co-ordination activity of mice compared with Control 
(p< 0.05).(Table II). 
The siddha preparation nayuruvi nei (15 and 30 ml/kg) was pharmacologically screened 
for its muscle relaxant study. The result indicates that siddha preparation nayuruvi nei (15 
and 30 ml/kg) possess a significant skeletal muscle relaxant activity in experimental 
animals. At dose of 15 and 30 ml/kg it showed highly significant skeletal muscle relaxant 
activity at 30min of duration.  Further studies are in progress to isolate the active 
constituents responsible for this activity. The muscle relaxation may be produced due to 
 depolarizing blockage of neuromuscular junction.Based on the results of the present 
study, we conclude that the siddha preparation nayuruvi nei (15 and 30 ml/kg) possess 
significant skeletal muscle relaxant activity. However, further studies are necessary to 
find the exact mechanism of skeletal muscle relaxant effect and to isolate the active 
compound(s) responsible for this pharmacological activity. 
 
Table I: Effect different treatment on duration of time spent on rotarod 
Group  Dose 0 minutes 30 minutes 
Normal control 10ml/kg saline 330.25 ± 22.85  322.7±24.85 
Diazepam 5mg/kg i.p 335.8±24.90 105.4±10.50** 
Nayuruvi nei 15ml/kg p.o 320.5±22.80 185.5±14.20* 
Nayuruvi nei 30ml/kg p.o 324.6±23.55 210.2±15.80* 
Values are expressed in mean± SEM; n=6; *p<0.05, *p<0.01 considered highly 
significant 
 
Table II: Effect of different treatment on motor co-ordination in mice 
Group  Dose  % Response 
Normal control 10ml/kg saline 0 
Diazepam 5mg/kg i.p 100 
Nayuruvi nei 15ml/kg p.o 69* 
Nayuruvi nei 30ml/kg p.o 61* 
 
Values are the percentage animals showing negative results; 
n = 6; *p< 0.05 compared with control (Chi-square test). 
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 ANTIMICROBIAL  STUDIES 
AIM 
  To study the Anti-microbial action of   Nayurvi  Nei  against  E-coli, 
Klebseilla. 
MEDIUM  
 Muller Hinton agar 
COMPONENTS OF MEDIUM  
 Beef extract   - 300gms/lit 
 Agar    - 17gms/lit 
 Starch   - 1.5gms/lit 
 Casein Hydroxylate - 17.5gms/lit 
 Distilled water  - 1000ml 
 PH    - 7.6 
PROCEDURE 
 The media was prepared from the components and poured and dried on a 
petri dish. The organism was streaked on the medium and the test drug  (1gm drug 
in 10ml water) was placed on the medium. This is incubated at 37C    for one over 
night and observed for night and observed for the susceptibility shown up 
clearance around the drug. 
RESULT: 
 The test drug Nayurvi  Nei  was Moderately sensitive against E-coli, 
Klebseilla. 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
  
GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI 
PG. DEPT. OF KUZHANTHAI MARUTHUVAM 
CONSENT FORM 
______________________________________________________ 
 An open clinical study to evaluate the safety and efficacy of Siddha sasthric 
formulation“NAYURUVI NEI”for the management “KUDAL KIRUMI - MASARAI 
PUZHU”             
                                       CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms 
readily understood by the parent. 
Date ……………….     Signature………….. 
place ……………….     Name ……………… 
CONSENT OF INFORMANT 
 I have been informed to my satisfaction, by the attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up 
including the laboratory investigations to be performed to monitor and safeguard 
my Son / Daughter body functions. 
 I am aware of my right to opt out of the trial at any time during the course of 
the trial without having to give the reasons for doing so. 
 I am, exercising  my free power of choice; hereby give my consent to be 
included as a subject in the clinical trial of “NAYURUVI NEI”for the treatment of  
“KUDAL KIRUMI - MASARAI PUZHU” 
       Informant Signature:………. 
Date:        Informant  Name: …………. 
Place:       Patient Name:………………. 
Signature of Witness     Relationship:………………… 
     
  
ANNEXURE – IV 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
BRANCH IV – KUZHANTHAI MARUTHUVAM 
PALAYAMKOTTAI - 627 002. 
CASE SHEET PROFORMA-“KUDAL KIRUMI-MASARAI PUZHU” 
Name of the Medical unit:    Nationality: 
I.P.No.  :     Religion:  
Bed. No. :      Date of Admission: 
Name :      Date of Discharge: 
Age/Sex:      Duration of treatment :  
Occupation(Parents):    Diagnosis: 
Income(Parents):     Medical Officer: 
Informant: 
Address: 
Complaints and duration  : 
History of present illness  : 
History of past illness  : 
Antenatal History   : 
Birth and Neonatal History  : 
Dietetic and Nutritional History : 
Developmental History  : 
Family History   : 
Social History    : 
Immunization History  : 
      General Examination  
1. Consciousness  : 
2. Decubitus  : 
3. Anemia  : 
 4. Jaundice  :  
5. Cyanosis  : 
6. Clubbing  : 
7. Pedal oedema  : 
8. Lymphadenopathy  : 
9. Nourishment  : 
10. Skin changes  : 
Vital Signs 
1. Pulse 
      -Rate  : 
      -Rhythm  : 
      -Volume  : 
      -Character  : 
      2.  Blood Pressure (B.P).  : 
      3. Respiratory Rate (R.R.)  : 
      4. Temperature  : 
      Anthropometry 
1. Wt – Weight  : 
2. Ht  -  Height  : 
3. Mid arm circumference  : 
4. Head circumference  : 
5. Chest  : 
6. Skin fold thickness  : 
Siddha Systems – Clinical Examination: 
Poripulangal 
           Mei  : 
           Vai  : 
           Khan  : 
           Mookku  : 
            Sevi  : 
Kanmendriyam – Kanmavidayam 
           Kai  : 
           Kaal  : 
           Vaai  : 
           Eruvaai  : 
           Karuvaai  : 
  : 
 
Nilam 
           Kurinchi  : 
           Mullai  : 
           Marutham  : 
           Neithal  : 
           Palai  : 
Paruva Kaalam 
           Kaar  : 
           Koothir  : 
           Munpani  : 
           Pinpani    : 
           Elavenil   : 
           Muthuvenil  : 
Udal Kattugal 
             Saaram  : 
             Senneer  : 
             Oon  : 
             Kozhuppu  : 
             Enbu  : 
             Moolai  : 
              Sukkilam/Suronitham  : 
Envagai Thervugal 
Naadi  : 
Sparisam  : 
Naa  : 
Niram  : 
Mozhi  : 
Vizhi  : 
Malam  : 
Moothiram  : 
   Vatham 
               Piranan  : 
              Abaanan  : 
              Uthaanan  : 
              Viyaanan  : 
              Samaanan  : 
              Naagan  : 
              Koorman  : 
              Kirugaran  : 
              Devathathan  : 
              Dhananjeyan  : 
 
Pitham 
                Analam  : 
              Ranjagam  : 
              Sathagam  : 
              Alosagam  : 
              Pirasagam  : 
 
  
Kabam 
              Avalambagam  : 
              Kilethagam  : 
              Pothagam  : 
              Tharpagam  : 
              Santhigam  : 
Neerkuri 
              Niram  : 
              Manam  : 
              Nurai  : 
              Edai  : 
              Enjal  : 
 
 Neikuri 
 Malakuri 
              Nirami  : 
              Nurai  : 
              Elagal  : 
              Erugal  : 
Modern Aspects 
Systemic examination 
Cardiovascular systems: 
1. Inspection: 
2. Palpation: 
3. Percussion: 
4. Auscultation: 
Examination of other systems 
Respiratory systems: 
 Abdomen: 
Central nervous systems: 
Excretory systems: 
Lab Investigations 
1. Blood 
TC : 
DC : 
Hb : 
ESR : 
PCV : 
MCV : 
MCH : 
MCHC : 
Total RBC count : 
Peripheral blood smear : 
 
2. Urine 
Albumin : 
Sugar : 
Deposits : 
Bile Salt : 
Bile pigments : 
3. Motion 
Ova : 
Cyst : 
Occult blood : 
 
 
 
  
DIFFERNTIAL DIAGNOSIS  : 
PROGNOSIS   : 
MARUTHUVAMURAI   : 
ADVICE   : 
DAILY PROGRESS   : 
 
Date 
 
Symptoms Medicine 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
BRANCH IV – KUZHANTHAI MARUTHUVAM 
PALAYAMKOTTAI - 627 002. 
ADMISSION – DISCHARGE SHEET 
Name of the medical unit :  Nationality: 
I.P.No                                :  Religion: 
Bed No                              :  Informant: 
Name                                 :  Date of Admission: 
Age/Sex                             :  Date of Discharge: 
Occupation(parents)          :  No. of days treated : 
Income(parents)                 :   Diagnosis   
S.No Clinical Features During 
admission 
During 
discharge 
1. Pain Abdomen   
2. Itching around the anus   
3. Loss of appetite   
4. Vomiting   
5. Irregular Stools   
6 Loss of weight   
7. Teeth grinding   
8 Worms in Faeces   
 
Place: 
Date:   Signature of the Medical Officer, 
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